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by 
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Loma Linda University, September 2017 
Dr. William J. Pearce, Chairperson 
 
 Arteries are a dynamic tissue with multiple cell types that incorporate systemic 
and local factors to maintain homeostasis. Hypoxia stimulates capillary angiogenesis to 
effectively match metabolic demand with perfusion. With chronic hypoxia, vascular 
remodeling of even large vessels can occur. This predisposes to pathologic states as seen 
with atherosclerosis, hypoxic brain injury, myocardial ischemia, diabetes, and 
developmental anomalies. With this remodeling comes changes in vessel structure 
including medial thickness and organization of contractile proteins as well as changes in 
myogenic tone. All of these factors culminate in changes in status or behavior of the 
vascular smooth muscle within the vessel wall, likely secondary to changes in smooth 
muscle phenotype. This investigation examines the hypothesis that hypoxia induces 
vascular remodeling through transformation of vascular smooth muscle cell phenotype 
mediated by VEGF action directly on smooth muscle and indirectly through the 
endothelium. This was performed with harvested middle cerebral and common carotid 
arteries from fetal and adult sheep after exposure to a hypoxic setting (3280m for 110 
days) or normoxic setting (sea level). These arteries were then subjected to endothelial 
 xvii 
denudation or left intact and then underwent structural and functional contractility assays, 
immunoblotting, and immunohistochemistry either immediately after harvest or 
following in vitro treatment with organ culture. Hypoxia and VEGF in organ culture had 
similar effects on contractile function and reorganization of contractile proteins including 
mature and immature myosin heavy chains (MHC) isoforms, Smooth muscle-MHC and 
Non-muscle MHC respectively with Smooth muscle-alpha Actin (SM-AA). The 
endothelium appeared to be a significant component of VEGF alterations to contractile 
function and MHC:SM-AA re-organization and this was mediated in part through VEGF 
stimulation of the NO pathway. Hypoxic acclimatization was found to not only alter 
acute responses to contractile stimulants but to alter reactivity to future insults with 
VEGF. In conclusion, hypoxic vascular remodeling significantly alters vascular SMC 
function and phenotype through VEGF and endothelial regulation. 
 
  
 1 
CHAPTER ONE 
INTRODUCTION 
Arteries are dynamic tissues with multiple cellular players contributing to 
vascular growth, structure, and contractility to maintain homeostasis. Although arteries 
were originally thought to act as static conduit vessels, the last decade has provided a new 
wave of studies that demonstrate the responsive remodeling of small and even large 
arteries under physiological and pathological conditions (13, 28, 33). A key aspect of this 
new paradigm is the role of the Vascular Smooth Muscle cell (VSMC) phenotype present 
within the artery wall (28). The VSMC phenotype regulates the vessel structure, the 
functional response to contractile stimulus, and in part the regulation of new blood vessel 
development (13, 28) (37). At least four stable phenotypes have been recognized: 
migratory, proliferative, synthetic, and contractile with the last two contributing largely to 
the contractile infrastructure and force-apparatus of the artery (29, 33). Synthetic VSMCs 
synthesize and organize elastin and collagen, the principle components of the extra-
cellular matrix (ECM) that passively defines the majority of vascular tone (37). Similarly, 
fully differentiated contractile VSMCs actively constrict the vessel through Actin-Myosin 
cross bridge cycling and subsequent cell shortening. Smooth Muscle-alpha Actin (SM-
AA) and SM-Myosin Heavy Chain (SM-MHC) are key components for force-production 
and are established VSMC markers (13, 33). MHC isoforms SM-embryonic (SMemb or 
NM-MHC), SM1 and SM2 were recently found to have unique contractile characteristics 
(11). Additionally, expression of these isoforms is developmentally regulated and may 
prove to be distinctive determinants of both phenotype and contractility (8).  Each 
phenotype plays a different role in physiologic processes including blood pressure 
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regulation and angiogenesis as well as contributing to pathological processes as seen in 
tumorigenesis, macular degeneration, atherosclerotic lesion formation, and hypoxic 
remodeling, which can be particularly important during embryonic development (1, 7). 
In the developing fetus, hypoxia can occur as a consequence of placental 
insufficiency or maternal anemia and is a leading cause of premature birth (14). For 
neonates born pre-35 weeks of gestation, nearly 50% experience cerebral hemorrhaging 
due to compromised vascular development that can result in extensive neurological 
damage (10, 35) (22).  Hypoxia drives whole artery remodeling, augments the 
endothelium, thickens the medial smooth muscle and adventitia, and acts on even the 
non-cellular factors including the composition of the ECM (30, 31). However, the 
cellular mechanisms mediating these hypoxic effects are incompletely understood. 
Central to the hypoxic response is the activation of the Hypoxia Inducible Factor 
(HIF) family of transcription factors that upregulate genes for numerous adaptive proteins 
(17). HIF-1a plays a fundamental role by upregulating the potent pro-angiogenic factor 
Vascular Endothelial Growth Factor (VEGF) (6). VEGF is thought to act primarily on 
endothelial cells but has recently been found to act on other vascular cells as well, namely 
VSMCs (2, 18). VEGF binds to VEGF Receptors 1 and 2 (VEGFR1/2) that in turn 
activate ERK and PI3K to upregulate other pro-angiogenic genes (7, 36).  
During angiogenesis the endothelium releases vasotrophic factors that act on 
smooth muscle and initiate hypoxic vascular remodeling. VEGF may induce these 
intermediate vasotrophic factors from the endothelium or act directly on the smooth 
muscle itself. Two prominent vasotrophic factors from the endothelium that act on 
VSMCs are Endothelin (ET) and nitric oxide (NO) (19). Both compounds can act 
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immediately on contraction as well as stimulate long term changes in smooth muscle 
gene expression and phenotype (3, 4). 
 
Background and Significance 
Vascular adaptability is essential to cardiovascular homeostasis and acute local 
hypoxia is an important physiological stress that induces these vascular adaptations. 
However, recurring or chronic hypoxia results in various pathologies during development 
as well as later in life (27). Chronic prenatal fetal hypoxia is one such case that can occur 
with placental insufficiency and maternal hypertension or diabetes, affecting several 
areas of development including alveolar maturation in the lungs and cerebrovascular 
development (16, 30). Generally chronic hypoxia stimulates the fetal cardiovascular 
system to redirect cardiac output to favor the developing brain and heart. However, 
systemic changes in vascular function and structure occur that are collectively known as 
hypoxic vascular remodeling. 
Hypoxic vascular remodeling was first established as a fundamental fetal response 
to chronic hypoxia in the 1970s and has since been characterized extensively. Structural 
changes with hypoxia include thickening of the medial and adventitial wall, changes in 
ECM content, and a decreased contractile response as seen in both the pulmonary and 
cerebral circulation (24, 30). However, hypoxic remodeling has been found to vary with 
artery size, artery type, maturation and smooth muscle phenotype (33, 37). This may in 
large part be due to the inherent heterogeneity of the smooth muscle that synthesizes the 
ECM and drives the contractile response (28). While four functional phenotypic states 
(synthetic, proliferative, migratory, and contractile) have been identified, a continuum of 
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intermediate states exist (4, 33). This broad spectrum of phenotypes results from the 
differing sources of smooth muscle progenitor cells (mesoderm, neuroectoderm, 
epicardium, endothelium) (27) and the ability of VSMCs to undergo dramatic phenotypic 
modulation at all levels of maturity (13). Both result in a milieu of smooth muscle 
phenotypes present in a single vessel each of which differ in their response to a single 
stimulus such as hypoxia (37). It is because of this innate versatility of smooth muscle 
that hypoxic vascular remodeling can occur, enabling the vessel to adapt to chronic 
changes respective of local conditions (33). To better understand the remodeling process, 
the initial and final phenotypic state of the smooth muscle must be determined and which 
vasotrophic factors may have carried out this process must be identified. 
 
Hypoxia Inducible Factor (HIF) and its Primary Angiogenic Target VEGF 
In response to systemic hypoxia, the total oxygen-transporting capacity increases 
with the production of new erythrocytes following erythropoietin (EPO) synthesis in the 
liver and kidney (7). However, tissues can also respond locally to hypoxia by recruiting 
new microvessels to increase local blood perfusion. The formation of additional blood 
vessels is stimulated through the HIF family of transcription factors, and activation of 
target pro-angiogenic genes. HIF-1 is central to the hypoxic response pathway. It is a 
heterodimer of oxygen sensing HIF-1a and constitutively expressed HIF-1b that is 
activated under hypoxic conditions (36). Upon activation, HIF-1 binds and activates 
transcription of several pro-angiogenic genes including glycolytic enzymes, Insulin like 
Growth Factor II (IGF-2), endothelial Nitric Oxide Synthase (eNOS), and glucose 
transporters. Another target of HIF-1 and principle initiator of angiogenesis is VEGF 
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(17). VEGF is secreted from hypoxic tissue in a gradient-like fashion to induce vessel 
budding by activating the endothelial cells of nearby microvessels. Arterial endothelium 
is also responsive to VEGF and is an established source of vasotrophic factors for 
VSMCs (21).  
Two prominent trophic factors released from the endothelium are endothelin (ET) 
and nitric oxide (NO). ET-1 is a potent vasoconstrictor and contributes to cardiovascular 
disease, in part by stimulating VSMC proliferation and subsequent vascular hyperplasia 
as seen with atherosclerosis (19). VSMCs bear both G protein-coupled receptors ET-A 
(predominantly) and ET-B with downstream activation of phospholipase C, ERK and 
Ca2+release from the endoplasmic reticulum to stimulate contraction, migration, and other 
phenotype-dependent responses (20). In contrast, NO is a well-known vasodilator that 
also modulates smooth muscle toward the contractile, non-proliferative, non-migratory 
phenotype at physiological levels (4). Low or absent levels of NO are associated with 
active remodeling of the vessel, increased synthesis of ECM proteins, and accelerated 
formation of atherosclerotic lesions and hyperplasia (34). Under hypoxia, NO production 
is required for vascular remodeling to occur (34). Downstream of NO are several 
signaling pathways to accomplish this, including ERK, p38, and JNK that inhibit 
proliferative genes and cGMP-dependent protein kinase (PKG) to activate contractile 
genes (4, 21). Interestingly, VEGF has previously been found to upregulate NO in at least 
damaged endothelial cells, making NO a promising vasotrophic target downstream of 
hypoxia and VEGF. 
Given that vasotrophic factors (such as PDGF, FGF, ET, NO, and VEGF) are 
upregulated with hypoxia, and that hypoxic vascular remodeling changes each 
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component of the vessel wall (especially the adventitia and ECM), changes in smooth 
muscle phenotype may accompany or even direct this remodeling process. VEGF is 
central to hypoxic remodeling, activates the endothelium as well as the release of 
vasotrophic factors, and has been shown to stimulate non-endothelial cells including 
sympathetic neurons, macrophages, fibroblasts and recently smooth muscle cells (23, 28). 
Therefore, hypoxic vascular remodeling may occur through either direct action of VEGF 
on smooth muscle or through indirect action of VEGF on endothelium to modulate 
smooth muscle phenotype with subsequent ECM degradation/synthesis and changes in 
contractile characteristics. This was examined with this dissertation and is expounded 
upon in the following chapters. Synthetic and contractile markers of phenotype have been 
identified for smooth muscle, although few are expressed uniquely in a certain phenotype 
which prompted the quadrant analysis utilized in the studies discussed in subsequent 
chapters (13, 28). High SM-AA expression is distinct to VSMCs. SM-MHC are 
established contractile protein markers that recent studies have identified three main 
MHC isoforms for: SMemb, SM1, and SM2. Each MHC isoform has unique functional 
characteristics: SM2 is prevalent in fully mature contractile VSMCs while SM1 is 34 
residues longer, more prevalent in semi-mature VSMCs early in development and was 
shown to be more sensitive to ligand-induced than stretch-induced contraction in SM2 
knockout mice (15, 32). SMemb, also known as non-muscle MHC (NM-MHC), is highly 
expressed in embryonic vessels and is quickly upregulated during the transition to 
synthetic phenotype (12, 33). We provided a unique integration of these four markers to 
characterize phenotype-dependent actions of smooth muscle during hypoxic vascular 
remodeling. Of note, it has also recently come to light that the antibodies available for 
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SM1 in large mammals including ovine, bovine and human is not selective for SM1 alone 
and instead identifies both MHC isoforms SM1 and SM2. Therefore, myosin heavy 
chains were categorized into mature contractile SM-MHC (SM1 and SM2) and NM-
MHC (SMemb) in all studies described below.    
 
Significance 
From a basic science perspective, the significance of the proposed work is 
represented in the unique hypoxia-organ culture model and a new technical approach to 
identify the role of vasotrophic factors and smooth muscle phenotype in hypoxic vascular 
remodeling. Previous work has been limited to molecular perturbations in non-
physiological cell culture with functional assessment only possible in freshly dissected 
arteries. Here, we propose to couple chronic hypoxia in vivo to organ culture of large and 
small arteries in the presence of hypoxia-induced vasotrophic factors. This enables a 
mechanistic investigation of both age-dependent and artery type-dependent changes in 
the vasculature as well as exposure of the artery to specific vasotrophic factors (namely 
VEGF) while maintaining smooth muscle phenotype and physiologic cell-to-cell 
interactions. New isoforms of established smooth muscle markers were quantified in 
parallel high-resolution measurements for abundance and co-localization with functional 
partners (namely SM-AA). These molecular findings were coupled with robust functional 
endpoints of stress-strain relations to elucidate the functional role of these contractile 
proteins in maintaining vascular tone. Both of these techniques are unprecedented in fetal 
cerebral and carotid arteries and were repeated in adult arteries for developmental 
comparison. In light of this, the proposed work uniquely relates functional and molecular 
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analysis of novel phenotypic contributors to hypoxic vascular remodeling in both the fetal 
and adult vasculature. 
From a clinical perspective, this is of principle importance in the 
cerebrovasculature of neonates exposed to chronic hypoxia in utero as well as in the 
development of various pathologies that occur in adulthood including atherosclerotic 
lesion formation and hypertension. In the fetus, even brief periods of hypoxia can cause 
neuronal death and subsequent pediatric strokes, intracranial hemorrhage, and other 
patterns of cerebral damage resulting in significant neurological impairment and 
economic cost. Much of this is due to alterations of the vasculature that stem from 
changes in smooth muscle behavior and may be reversible if the mechanisms of action 
are elucidated. Similarly, in the adult, if phenotypic pressures toward VSMC proliferation 
and synthesis could be identified, pharmaceuticals could be developed to reverse or 
inhibit atherosclerotic lesion formation. Current therapies are already available for 
angiogenic factors such as VEGF that are known to contribute to hypoxic vascular 
remodeling. How such factors regulate hypoxic changes in smooth muscle phenotype and 
the functional and structural consequences of these changes remain highly uncertain. A 
better understanding of how the fetal and adult vasculature is altered by sustained 
hypoxia is needed to identify and optimize therapeutic strategies for these patients and is 
the objective of this dissertation. 
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Figure 1.  Hypoxic Vascular Remodeling.  
Hypoxia stabilizes transcription factor HIF, that then upregulates VEGF. VEGF stimulates 
the endothelium to release vasotrophic factors. These factors, specifically endothelin-1 and 
NO, stimulate phenotypic changes in the smooth muscle. VEGF may also act directly on 
the smooth muscle, altering its phenotypic state. Said phenotypic modulations result in 
structural and functional changes of the vessel including degradation/synthesis of the ECM 
and changes in stress-strain relations. 
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Hypoxia Modulates vascular function and SMC Phenotype 
As described above, hypoxia stimulates changes in vascular structure and the 
contractile response of smooth muscle. Contractile function is regulated by both 
intercellular and intracellular reactions. Intercellular actions include endothelium 
secretion of contractants and relaxants to the smooth muscle as well as smooth muscle 
active dispersion of force to the ECM. Intracellular regulation acts on cell-anchor 
components and force-producing components of the actin-myosin cross-linking. Many 
studies have focused on structural changes of the whole artery with hypoxia as well as 
intracellular signaling pathways.  Yet little is known of the long term effects of hypoxia 
on the expression and working interactions of contractile proteins specifically. 
These proteins combine to form a force-producing apparatus that can be activated 
through multiple stimuli and pathways. To separate out signaling pathways that initiate 
contraction, both stretch-induced (myogenic) stress and potassium-induced (active) stress 
were studied in conjunction with expression of contractile proteins. Both myogenic and 
active stress are thought to culminate in Ca++ activation of Myosin Light Chain Kinase 
(MLCK), phosphorylation of MLC20 and cross-bridge formation and movement along 
SM-AA. The uncoupling of these two forms of contraction under hypoxia suggest 
changes upstream of the contractile apparatus or in the components/response of the 
contractile apparatus itself. This could include changes in receptor coupling, Ca++ influx, 
or at the cross-bridge formation between actin and myosin via changes in the MHC 
isoform. Previous work has considered changes in Ca++ influx and sensitivity (25) (26). 
However, these were incomplete in their explanation.  
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 Shifts in smooth muscle phenotype and contractile markers are relevant to force 
production and a budding area of focus. There are 3 smooth muscle MHC isoforms: 
synthetic SMemb and the two contractile SM1 (immature) and SM2 (mature). To explore 
whether the type of MHC associated with SM-AA changed with hypoxia and 
development, MHC isoform abundance and co-localization with SM-AA were 
determined in ovine carotid arteries from non-pregnant adult sheep exposed to normoxic 
or hypoxic conditions.  
 
VEGF Modulates Trophic Influences of Arterial Endothelium 
During angiogenesis, VEGF acts on the microvascular endothelium (6). Recent 
evidence suggests VEGF also acts on arterial endothelium and may stimulate smooth 
muscle differentiation through the endothelial release of vasotrophic factors (21). To 
determine if hypoxia with VEGF might act through this mechanism in ovine arteries, we 
examined the effects of in vivo chronic hypoxia and organ culture with VEGF. For organ 
culture, matched segments from a single artery, half of which are endothelium-denuded 
and the other half endothelium-intact, were treated with vasotrophic factors or respective 
pathway inhibitors.  
 
Experimental Background 
The central hypothesis investigated in this dissertation was that hypoxia induces 
vascular remodeling through transformation of vascular smooth muscle cell phenotype 
mediated by VEGF action directly on smooth muscle and indirectly through the 
endothelium. This hypothesis was explored through two separate corollaries: Hypoxic 
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changes in SMC phenotype and vascular remodeling occur through Aim 1) Direct action 
of VEGF on smooth muscle as modeled in endothelium-denuded ovine carotid arteries; 
Aim 2) Direct action of VEGF on smooth muscle and indirect action of VEGF through 
the endothelium as modeled in endothelium-denuded and endothelium-intact ovine 
middle cerebral arteries. (Figure 10). To test these corollaries, arteries from normoxic 
fetal and adult sheep were placed in organ culture in the presence and absence of 
physiological levels of VEGF (3ng/mL) and other vasotrophic factors to investigate 
which hypoxic effects can be reproduced.  
Previous studies have demonstrated the dynamic nature of VSMCs when removed 
from arterial context (as seen with single cell culture, in co-cultures with endothelial 
cells, and in MatrigelTM cultures with synthetic ECM) (37) (38). Likewise, the presence 
of other growth factors including angiotensin-2, fibroblast growth factor, and 
transforming growth factor-b, significantly alters the VSMC phenotype (9) (32) (15). 
Given the variable growth factor content of Fetal Bovine Serum (FBS), and to identify 
the extent VEGF alone plays a role in hypoxic vascular remodeling, whole artery rings 
were cultured in minimal essential medium without FBS. All arteries designated for 
organ culture will undergo an initial 24hr serum-starvation period without VEGF as 
previously shown, to align VSMC cell cycle and to clear the culture of autocrine and 
paracrine factors (5). This would then be followed by 24 hour culture with and without 
VEGF followed by allocation of tissue towards three respective assays: (1) 
Measurements of MHC isoform abundance using calibrated Western blotting, (2) 
Measurements of MHC isoform co-localization with SM-αActin, and (3) functional 
contractility measurements of active and passive stress-strain relations. 
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Hypothesis of Dissertation 
To identify these endothelial and non-endothelial mitogenic actions of VEGF, this 
dissertation investigates the main hypothesis that hypoxia induces vascular remodeling 
through transformation of vascular smooth muscle cell phenotype mediated by 
VEGF.  This hypothesis gives rise to two specific corollaries: 1) chronic hypoxia 
stimulates phenotypic transformation and vascular remodeling through direct actions of 
VEGF on arterial smooth muscle; and 2) chronic hypoxia stimulates phenotypic 
transformation and vascular remodeling indirectly through VEGF-induced release of 
Endothelin and NO from the endothelium.  The following chapters address these 
corollaries: 
 
Chapter 2: Measure the effects of chronic hypoxia and VEGF on the 
organization and function of contractile proteins as indicated by medial thickness, artery 
stiffness, active stress-strain relations, and MHC markers of smooth muscle phenotype in 
endothelium-denuded ovine carotid arteries.  
 
Chapter 3: Measure the effects of chronic hypoxia and VEGF on the 
organization and function of contractile proteins in the presence or absence of NO, the 
eNOS inhibitor L-NAME, and/or Protein Kinase G (PKG) activator 8-pCPT-cGMP, as 
indicated by medial thickness, artery stiffness, active stress-strain relations, and MHC 
markers of smooth muscle phenotype in endothelium intact and denuded ovine middle 
cerebral arteries. 
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Chapter 4: Measure the change in response to VEGF in chronic hypoxia 
arteries on the organization and function of contractile proteins as indicated by medial 
thickness, artery stiffness, active stress-strain relations, and MHC markers of smooth 
muscle phenotype in endothelium-denuded ovine carotid arteries.  
 
Chapter 5: Measure the effects of chronic hypoxia and VEGF on the 
organization and function of contractile proteins in the presence or absence of ET, ET 
receptor inhibitors BQ-123 and BQ-788 as indicated by medial thickness, artery stiffness, 
active stress-strain relations, and MHC markers of smooth muscle phenotype in 
endothelium intact and denuded ovine middle cerebral arteries. 
To define the effects of hypoxia, arteries were studied from animals maintained at 
sea level and after acclimatization to an altitude of 3280m for 110 days.  To identify 
developmental and maturational differences in mechanisms mediating hypoxic vascular 
remodeling, these experiments were carried out in arteries from term fetal lambs and non-
pregnant, nulliparous young ewes.  To assess the role of VEGF, arteries were organ 
cultured in either the presence or absence of media containing low physiological 
concentrations (3-30 ng/ml) of VEGF.  Smooth muscle phenotype was evaluated by the 
extent of SM-AA co-localized with either the immature (SMemb aka Non-Muscle) or the 
the mature Smooth Muscle isoforms (SM1 and SM2) of Myosin Heavy Chain (MHC) 
isoforms of myosin heavy chain (MHC).  Together, these measures offer an original 
perspective of the age-dependent mechanisms through which hypoxia mediates vascular 
remodeling.  
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Figure 2. Main experimental paradigm. 
Hypoxic alterations to SMC phenotype as well as artery structure and function were 
determined in ovine fetal and adult, middle cerebral and carotid arteries using 3 different 
assays:  changes in contractile protein abundance (Immunoblotting), changes in the 
organization of contractile proteins (Confocal Immunofluorescent), and changes in 
contractile function (stress-strain relations). To determine the role of VEGF and the 
endothelium in this process, matching artery segments were organ cultured with or without 
VEGF, intact endothelium, and/or vasotrophic factors. 
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Abstract 
Chronic hypoxia increases Vascular Endothelial Growth Factor (VEGF) and 
thereby promotes angiogenesis. The present study explores the hypothesis that hypoxic 
increases in VEGF also remodel artery wall structure and contractility through 
phenotypic transformation of smooth muscle. Pregnant and non-pregnant ewes were 
maintained at sea level (normoxia) or 3,820m (hypoxia) for the final 110 days of 
gestation. Common carotid arteries harvested from term fetal lambs and non-pregnant 
adults were denuded of endothelium and studied in vitro. Stretch-dependent contractile 
stresses were 32% and 77% of normoxic values in hypoxic fetal and adult arteries. 
Hypoxic hypo-contractility was coupled with increased abundance of Non-Muscle 
Myosin Heavy Chain (NM-MHC) in fetal (+37%) and adult (+119%) arteries. 
Conversely, hypoxia decreased Smooth Muscle MHC (SM-MHC) abundance by 40% in 
fetal arteries but increased it 123% in adult arteries. Hypoxia decreased colocalization of 
NM-MHC with Smooth Muscle-Alpha Actin (SM-AA) in fetal arteries and decreased 
colocalization of SM-MHC with SM-AA in adult arteries. Organ culture with 
physiological concentrations (3 ng/ml) of VEGF-A165 similarly depressed stretch-
dependent stresses to 37% and 49% of control fetal and adult values. The VEGF receptor 
antagonist vatalanib ablated VEGF’s effects in adult but not fetal arteries, suggesting age-
dependent VEGF receptor signaling. VEGF replicated hypoxic decreases in 
colocalization of NM-MHC with SM-AA in fetal arteries and decreases in colocalization 
of SM-MHC with SM-AA in adult arteries. These results suggest that hypoxic increases 
in VEGF not only promote angiogenesis, but may also help mediate hypoxic arterial 
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remodeling through age-dependent changes in smooth muscle phenotype and 
contractility.  
 
Key Words 
Confocal Colocalization, Non-Muscle Myosin Heavy Chain, Organ Culture, Smooth 
Muscle Phenotype, VEGF Receptors 
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Introduction 
Vascular remodeling is a highly dynamic process that continuously matches tissue 
perfusion to changing metabolic demands (59). Patterns of vascular remodeling vary 
greatly in relation to vessel type, size, age, and anatomical location (31, 60) and are 
particularly important during periods of rapid growth, such as those occurring in a mother 
and fetus during pregnancy and following birth (31, 46). Vascular remodeling is also a 
driving influence of many pathophysiological processes, particularly those induced by 
chronic hypoxia (23, 68), ischemia (41), hypertension (66), and atherosclerosis (50). 
Remodeling alters the shape and size of arterial smooth muscle cells (18, 59) with 
corresponding changes in contractility and vascular reactivity (31, 33, 38). These changes 
in structure and function are presumably coupled with transformations of smooth muscle 
phenotype, which can be identified by characteristic changes in key contractile proteins 
(31, 49). In turn, changing abundance of smooth muscle-Alpha Actin (SM-AA) (44, 45) 
together with other contractile proteins, such as myosin heavy chain (MHC) isoforms (49, 
50) reliably and dynamically reveal corresponding changes in smooth muscle phenotype 
during both physiological (31), and pathophysiological (23, 59, 66) vascular remodeling. 
The exact mechanisms that drive vascular remodeling and phenotypic 
transformation of smooth muscle remain poorly understood but appear to include the 
actions of a broad variety of growth factors including fibroblast growth factor (48), 
platelet-derived growth factor (21), transforming growth factor-β (6), and vascular 
endothelial growth factor (28, 44). Some vasotrophic factors originate from local 
metabolically active parenchymal cells and act primarily at the serosal surface of blood 
vessels (1), whereas others such as endothelin and NO (10, 15), emanate from the 
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vascular endothelium and act more prominently at the luminal surface. Others are 
released into both the interstitium and the bloodstream and thereby coordinate widely 
distributed effects on vascular structure and function. An excellent example in this latter 
category is Vascular Endothelial Growth Factor (VEGF). Long recognized as a key 
mediator of angiogenesis (16), VEGF also can exert trophic effects on non-endothelial 
cell types including pericytes (61), CNS neurons (32), astrocytes (22), Schwann cells 
(58), sympathetic neurons (39), skeletal muscle (9) and smooth muscle (11, 26, 43). 
Equally important, the synthesis and release of VEGF are strongly stimulated by hypoxia 
via multiple pathways (20, 62). Together, these characteristics give VEGF the potential to 
broadly influence vascular remodeling and phenotypic transformation of smooth muscle, 
particularly in response to chronic hypoxia. 
The present study explores the hypothesis that VEGF may contribute to age-dependent 
hypoxic remodeling of artery structure and function through changes in contractile 
protein abundance and organization secondary to changes in smooth muscle phenotype. 
In the context of this study, artery “structure” was assessed through measurements of 
medial layer thickness, unstressed diameter, and the transmural distribution and 
intracellular organization of smooth muscle contractile proteins. In turn, intracellular 
organization and smooth muscle phenotype were defined by the patterns of colocalization 
of Non-Muscle and Smooth Muscle Myosin Heavy Chain with Smooth Muscle- Actin 
(49, 50). The experimental design focused first on the effects of chronic hypoxia on 
artery structure, contractile protein organization, and function using established methods 
for immunoblotting, confocal microscopy, and measurements of in vitro contractility (11, 
14). The same endpoints also helped define the structural and functional effects of organ 
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culture with VEGF in a second tier of experiments. These experiments employed VEGF 
at 3 ng/ml, a low physiologically relevant concentration (19, 64) that minimized non-
specific activation of non-VEGF receptors (4). To minimize influences attributable to the 
release of parenchymal metabolites, we performed all measurements in carotid arteries. 
Comparisons between arteries harvested from sheep maintained at sea level, and those 
maintained at high altitude (3820 m) for 110 days served to define the effects of chronic 
hypoxia, as previously described (47). Because vascular remodeling manifests very 
differently in mature and immature arteries (12), the experimental design also included 
comparisons between arteries harvested from non-pregnant adult sheep and term fetal 
lambs. Together, these approaches enabled a unique perspective of the role of VEGF in 
age-dependent hypoxic vascular remodeling.  
 
Materials and Methods 
  All procedures used in these studies were approved by the Animal Research 
Committee of Loma Linda University, adhered to the policies and practices set forth by 
the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and 
have been previously described in detail (11, 67). 
 
Tissue Harvest and Preparation 
Common carotid arteries were harvested using sterile techniques from fetal (139-
142 days gestation) and young non-pregnant adult sheep (18-24 month old) that had been 
maintained at either sea level (Normoxic) or at 3820 m for 110 days (Hypoxic). Hypoxic 
acclimatization occurred during the final 110 days of gestation for pregnant ewes. For 
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tissue harvest, pregnant ewes were anesthetized with 30 mg/kg pentobarbital, intubated, 
and then placed on 1.5%-2.0% halothane. The fetus was then exteriorized through a 
midline vertical laparotomy and sacrificed by rapid removal of the heart and 
exsanguination. Adult animals were sacrificed by intravenous administration of 100 mg/kg 
IV pentobarbital. Harvested arteries were placed in sterile HEPES buffer solution 
containing in mM: 122 NaCl, 25.0 HEPES, 11.1 dextrose, 5.15 KCl, 2.40 MgSO4, 1.6 
CaCl2 and 0.050 EDTA. Following gentle removal of extracellular and loose connective 
tissue the arteries were mechanically denuded of endothelium, as previously described 
(67). The denuded carotid segments were cut into segments 2 to 3 mm in length, then 
distributed to the various protocols. 
 
Organ Culture 
As described previously (11), artery segments designated for organ culture were 
maintained in untreated 12-well plates with DMEM (Sigma Aldrich, St. Louis, 
#M56469C) supplemented with: Na2HCO3 (3.7 g/L), 0.5% amino acid solution (Sigma 
Aldrich, St. Louis, #M5550), 1% non-essential amino acid solution (Sigma Aldrich, St. 
Louis, #M7145), 4 mM glutamine (Sigma Aldrich, St. Louis, #G7513), 2% antibiotic-
antimycotic solution (Gibco, Carlsbad, #15240-096), and Gentamycin at 70 µg/ml 
(Gibco, Carlsbad, #15750-060). Cultures were maintained in a humidified incubator with 
5% CO2 in room air at 37 ºC. 
Matched artery segments were cultured in supplemented DMEM without FBS for 
the initial 24 hours and for an additional 24 hours in media containing either DMEM 
(Control), 3 ng/ml VEGF-A165 (VEGF), or 3 ng/ml VEGF-A165 plus the selective VEGF 
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receptor inhibitor vatalanib at 240 nM (35) (VEGF+Vat). Preliminary dose-finding 
studies at vatalanib concentrations between 120–1200 nM were performed to identify the 
optimal concentration for inhibition of VEGF effects, which was 240 nM. The 
concentration of VEGF used (3 ng/ml) was chosen to mimic serum levels measured in 
pregnant sheep (64) and to minimize nonspecific binding of VEGF to other receptors (4). 
Following organ culture, arteries were allocated for analysis via fluorescent 
immunohistochemistry, Western blots, or contractility studies. Matched fresh uncultured 
artery segments were studied in parallel for all cultured treatments and subsequent assays.  
 
Contractility Studies 
Artery segments designated for contractility measurement were wire-mounted in 
vitro between an isometric force transducer and a micrometer slide used to set artery 
diameters. Mounted segments were first equilibrated for 30 min in calcium-replete Na+-
Krebs buffer containing (in mM) 122 NaCl, 25.6 NaHCO3, 5.17 KCl, 2.56 dextrose, 2.49 
MgSO4, 1.60 CaCl2, 0.114 ascorbic acid, and 0.027 EGTA. Buffer pH was maintained at 
≈7.4 with continuous bubbling of 95% O2, 5% CO2 at normal ovine core temperature of 
38 OC. After initial equilibration, the unstressed artery diameter (D0) of each segment was 
measured at a passive tension of 0.03 g. Working diameters (D) were calculated for each 
artery based on its D0 at strain ratios of D/D0 = 1.5, 1.8, 2.1, 2.4, 2.7, 3.0, and 3.3. 
Contractile stresses in dynes/cm2 were recorded at each of these strain values, in 
increasing order under resting conditions to determine spontaneous myogenic stress, 
followed by contraction in a high potassium buffer containing (in mM) 122 KCl, 11.1 
Dextrose, 5.16 NaCl, 2.50 MgSO4, 2.15 NaHCO3, 1.60 ml CaCl2, 0.114 Ascorbic Acid, 
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and 0.027 EDTA. After K+-induced contractions had stabilized, arteries were returned to 
Na+-Krebs buffer, allowed to relax, then stretched to and equilibrated at the next highest 
stretch ratio. Once the K+-induced contraction had been measured at the maximum D/D0 
ratio of 3.3, the arteries were frozen in liquid nitrogen to rupture the cells, and then 
incubated in a calcium free Na+-Krebs buffer containing 3 mM EGTA to further inhibit 
smooth muscle cell derived-force through Ca2+ sequestration. The level of passive stress 
produced at each strain ratio used was then recorded at each descending stretch ratio. 
Myogenic stresses were calculated as the spontaneous stresses measured under resting 
conditions at each strain ratio (D/D0) minus the passive stresses measured after freezing 
in liquid N2 at the same strain ratio. The potassium-induced stresses were calculated as 
the maximum stresses measured during exposure to high potassium at each strain ratio 
(D/D0) minus the spontaneous stresses measured under resting conditions at the same 
strain ratio. Arterial stiffness was determined using the relations between strain and 
passive stress, using curve-fitting with a monotonic exponential model to determine the 
coefficient of stiffness. All methods used to quantify contractility have been previously 
described in detail (11). 
 
Fluorescent Immunohistochemistry 
Matched artery segments were fixed in 4% neutral buffered EM-grade 
formaldehyde (Electron Microscopy Sciences, Hatfield, #15713S) for 48 h at 4OC. 
Segments were dehydrated and embedded in paraffin, sectioned at 5 µm, and mounted on 
slides. Sections were deparaffinized in Histo-Clear (National Diagnostic, Atlanta, #HS-
200), rehydrated in decreasing concentrations of alcohol, and then microwaved in a 
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citrate buffer (pH 6.03) to retrieve antigenicity. Permeabilization and blocking was done 
with 0.1% Triton X-100 (Sigma Aldrich, St. Louis, #T-8787) and 1% Bovine Serum 
Albumin (Santa Cruz Biotechnology, Santa Cruz, #SC-2323) in PBS. To detect for 
changes in phenotype, artery sections were probed with antibodies to reveal expression of 
Non-Muscle Myosin Heavy Chain (NM-MHC), which is a marker for incompletely 
differentiated, partially contractile smooth muscle, and Smooth Muscle Myosin Heavy 
Chain (SM-MHC), a marker for differentiated, contractile smooth muscle (49, 50). 
Although the amino terminus of MHC can include a 7 amino acid insert in phasic smooth 
muscle (the MHC-B family), arterial MHC consistently lacks this insert (the MHC-A 
family) (17), and thus these studies assumed that all MHC detected was of the MHC-A 
family of smooth muscle myosin isoforms. 
  Arterial sections were exposed to primary antibodies overnight with polyclonal 
rabbit anti-human Non-Muscle Myosin Heavy Chain (NM-MHC; CoVance, Princeton, 
PPR-445P) at 1:500 or polyclonal rabbit anti-bovine Smooth Muscle Myosin Heavy 
Chain (SM-MHC; Abcam, Cambridge, ab53219) at 1:500. The following day, slides 
were washed for two 10-minute cycles in PBS and incubated using the appropriate 
secondary antibody with DyLight 488 Conjugated (Pierce Chemical, Rockford, #35502) 
for two hours at room temperature. The secondary antibody was a goat anti-rabbit-488 
(Thermo Scientific, Rockford, #35552 Lot LI150311). To minimize photobleaching of 
the fluorescent dyes, slides were stored in the dark. Following two 10-minute cycles in 
PBS, tissue slides were coverslipped using SlowFade Gold anti-fade reagent with DAPI 
(Invitrogen, Carlsbad, S36939) then stored until imaged. All images were captured using 
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a Zeiss AXIO Imager A1 fluorescence microscope and Spot software (Diagnostic 
Instruments, Inc. Ver 4.6.4.5). 
 
Transmural Morphometry 
As previously described in detail (11), artery sections processed for fluorescent 
immunohistochemistry were analyzed using standard morphometric procedures to 
quantify the distribution of contractile proteins across the artery wall. For this analysis, 
six individual line-intensity scans were recorded along radial lines extending from the 
basal lamina to the adventitial-medial junction using Image Pro Plus (Media Cybernetics, 
Version 6.0). The radial scan lines mapped fluorescent intensity versus distance from the 
lumen and were equally distributed at 60-degree increments around the lumen. Distance 
measurements were normalized to medial thickness with a value of “0” assigned to the 
region just inside the basal lamina and a value of “100” assigned to the region just inside 
the adventitial-medial junction. Following published procedures (11), separately 
determined calibration curves were used to convert fluorescent intensities into relative 
fluorophore concentrations, and thereby linearize estimates of signal intensities and 
corresponding regional antigen concentration. These estimates were averaged as a 
function of relative distance from the lumen for all line scans from the same section. The 
“Inner”, “Middle”, and “Outer” regions were averaged across values from 5-20%, 45-
60%, and 80-95% of the normalized distance from the lumen respectively. The innermost 
5% and outermost 5% of the medial layer were excluded to avoid autofluorescent 
contamination from the basal elastic lamina and adventitial elastin and collagen, 
respectively. These lines determined the relative distribution of each marker across the 
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artery wall. The absolute abundance of each marker in the whole artery wall was 
determined by semi-quantitative Western blot. For each marker, the area beneath the 
distance-concentration curves were normalized to 100%, then multiplied by the Western 
blot values to calculate relative local abundance values that could be compared between 
regions and experimental groups. 
 
Confocal Microscopy 
Matched artery segments were collected, prepared and cut into 5 μm sections, 
deparaffinized, sectioned, and immunostained as described for Transmural Morphometry, 
with the exception that all sections were stained with primary monoclonal mouse anti-
sheep antibodies against SM-AA (Sigma-Aldrich, A5228, 1:200) and a second primary 
antibody against one of the MHC isoforms. Because in arterial smooth muscle the  
isoform of actin is the main isoform involved in smooth muscle contraction (45), all 
colocalization of MHC was quantified relative to the abundance of  actin.  Because 
only alpha actin is involved in smooth muscle contraction, changes in the other actin 
isoforms that can also be expressed in smooth muscle (45) should have little if any 
influence on smooth muscle contractility. The antibodies used to detect the MHC 
isoforms were as described in the Fluorescent Immunohistochemistry section. Following 
incubation with the primary antibodies, sections were washed in PBS, equilibrated in 
darkness for 2 h at room temperature with two secondary antibodies labeled with 
Dylight-488 to detect SM-AA and Dylight-649 to detect MHC, as indicated for 
Fluorescent Immunohistochemistry. Following secondary staining, sections were cover-
slipped using Slowfade Gold Antifade Reagent (S36936, Invitrogen), and then examined 
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with an Olympus FV1000 confocal microscope at an optical section thickness of 0.7 μm, 
a lateral resolution of 200 nm, and a numerical aperture of 18.  
Antigen colocalization in confocal images was analyzed using FlouView software 
(version 2.1c), which provided multiple indices of co-localization including the Manders 
Colocalization Index 1 (actin signal in the denominator) that quantifies the portion of 
pixels that fluoresce for both MHC and SM-AA relative to the total number of pixels 
positive for SM-AA. Positive pixels were defined as having a fluorescent intensity equal 
to or greater than 5% of the maximum fluorescence intensity in the section. To eliminate 
cells with a small but significant above-threshold abundance of SM-AA characteristic of 
incompletely differentiated smooth muscle cells and some non-smooth muscle cell types 
(55), a second index of colocalization was developed. This second index, which we 
termed %Upper Right (%UR), was calculated to select for differentiated contractile 
smooth muscle as identified by high SM-AA abundance levels. This index counted only 
pixels that fluoresced at or above the mean intensity threshold for SM-AA, which in 
essence was equivalent to recalculating the Colocalization Index 1 with an SM-AA 
threshold of 50% of maximum intensity. This method of analysis was derived from a 
flow-cytometry quadrant analysis, and thus was referred to as the percentage in the upper 
right quadrant of the scatterplot of SM-AA intensities against MHC intensities. From a 
general perspective, Colocalization Index 1 and %UR were both proportional to the 
fraction of actin-positive pixels that were also positive for MHC. Interestingly, the results 
obtained for both Colocalization Index 1 and %UR varied somewhat in absolute values, 
but were qualitatively similar. 
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Immunoblotting 
Artery segments were homogenized via glass on glass in 8 M Urea, 500 mM 
NaCl, 23 mM Glycine, 20 mM Tris, 10 mM EGTA, and 10% Glycerol at pH 8.6 with the 
addition of a protease inhibitor cocktail at 5 µl per ml of buffer (Sigma-Aldrich, Saint 
Louis, #M1745) that included (final concentrations): 52 mM AEBSF, 2 mM Bestatin, 1 
mM Leupeptin, 750 µM Pepstatin A, 700 µM E-64, and 40 µM Aprotinin. Centrifugation 
of the homogenate at 5,000 G for 20 minutes yielded a supernatant in which protein 
concentration was determined using the Bio-Rad Bradford assay. Optimal masses of total 
soluble protein in the extracted supernatant were loaded after which the proteins were 
separated by SDS-PAGE alongside pooled reference standards prepared from adult ovine 
common carotid arteries used to calibrate sample abundances on each gel. Separated 
proteins were transferred to nitrocellulose at 350 mA for 90 minutes in Towbin’s buffer 
(192 mM Glycine, 25 mM Tris, Methanol-10% for MHC and 20% for SM-AA) with 
beta-mercaptoethanol added to the upper buffer reservoir. Membranes were blocked with 
5% milk in Tris-buffered saline at pH 7.5 (M-TBS) for 1 hour at room temperature using 
continuous shaking. All subsequent washes and incubations were done in M-TBS with 
0.1% Tween-20. Membranes were incubated with the same primary antibodies listed 
above at the following concentrations: anti-SM-AA 1:3000, anti-NM-MHC 1:1000 and 
anti-SM-MHC 1:20,000 for 3 hours. For visualization, membranes were incubated for 90 
minutes with a secondary antibody conjugated to DyLight 800 (Pierce Chemical, 
Rockford, #46422) and imaged on a LI-COR Bioscience’s Odyssey system.  All protein 
abundances were expressed as the equivalent mass of standard relative to the mass of 
protein loaded in each lane.  
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Data Analysis and Statistics 
Contractile stresses were calculated as ratios of force per cross-sectional area, 
where force was calculated as contractile tension in grams times the acceleration due to 
gravity. Cross-sectional area (wall thickness x segment length) was corrected for changes 
with stretch as described previously (30, 46). Stress values were normalized within each 
artery segment by calculating the percent of the maximum force produced by the artery 
exerted at each stretch ratio. Percent maximum values were converted back into absolute 
units of stress by multiplying by the average maximum stress calculated across all 
segments within the same experimental group. 
Immunofluorescence intensity values were recorded as a function of relative 
radial distance from the lumen to the adventitia, then normalized within each segment to 
yield an area beneath the intensity-distance curve of unity, as previously described in 
detail (11). Fluorescence intensity values were calibrated against relative marker 
abundance measured with Westerns, which in turn were calibrated for each marker 
against a standard curve pooled from adult common carotids. For confocal colocalization, 
all values were calculated among SM-AA positive pixels and determined the fractions of 
those pixels also positive for each of the MHC isoforms. The total colocalization values 
were obtained by adding the individual colocalization index values for each of the MHC 
isoforms, and the group error was calculated as a pooled variance. All statistical 
comparisons were done using Behrens-Fisher comparison at the P<0.05 level with each 
animal contributing equally to each treatment group.  
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Results 
A total of 174 endothelium-denuded carotid artery segments were harvested from 
8 normoxic fetuses (FN), 7 hypoxic fetuses (FH), 11 normoxic adults (AN), and 8 
hypoxic adults (AH). When duplicate segments from a single animal were used in the 
same protocol, the resulting values were averaged and the resulting average was treated 
as a single observation. Throughout the text, “n” denotes the number of animals used in 
each experiment, not the number of segments. Statistical significance was defined at P < 
0.05 for all assays, with all values given as means ± SEM. 
 
Chronic Hypoxia Altered Age-Dependent Contractile Function of Large 
Arteries  
Normoxic values of medial wall thicknesses and unstressed diameters were 
significantly less in fetal than in adult arteries, and these values were not significantly 
different than age-matched hypoxic values (Table 1). Maximum stretch-dependent 
stresses were significantly greater in fetal than in adult arteries, and were significantly 
less in hypoxic than in normoxic arteries from both age groups (Figure 1). Conversely, 
maximum K+-induced stresses were significantly greater in adult than in fetal arteries 
and were decreased only modestly by hypoxia in both age groups. 
 
Chronic Hypoxia Altered Age-Dependent MHC Abundance and Distribution 
Relative abundances of the embryonic isoform of MHC (NM-MHC) were 
significantly greater in fetal than adult arteries and were similarly increased by hypoxia in 
both age groups. Normoxic fetal values averaged 1,350% of normoxic adult values, and 
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hypoxic fetal values averaged 850% of hypoxic adult values (Figure 2). In hypoxic 
arteries, NM-MHC abundance values averaged 137% and 216% of normoxic values in 
fetal and adult arteries, respectively. In normoxic fetal arteries, the regional abundance of 
NM-MHC (in µg / µg standard) was significantly greater in the inner medial region (7.87 
± 0.67) than in either the middle medial (4.82 ± 0.33) or outer medial (4.75 ± 0.42) 
regions (Figure 2). A similar pattern was observed across the inner medial (9.90 ± 1.11), 
middle medial (6.94 ± 0.74) and outer medial (7.03 ± 0.76) regions of hypoxic fetal 
arteries. In adult arteries, NM-MHC abundance values did not vary significantly among 
regions in either normoxic or hypoxic arteries.  
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Table 1. Effects of Hypoxia and VEGF on Artery Structure and Function 
  Medial 
Thickness 
(µm) 
Unstressed 
Diameter 
(µm) 
Stretch-Dependent 
Maximum Stress 
(dynes/cm2) 
K+-Induced 
Maximum Stress 
(dynes/cm2) 
Fetal Normoxic 203±18 A 2,900±290 A 19,730±6,460 A,H 6,370±1,890 A 
 Hypoxic 221±21 A 3,230±250 A 6,280±1,220 A,H 5,240±1,170 A 
Adult Normoxic 543±25 A 4,020±310 A 8,600±1,730 A,H 31,220±3,530 A 
 Hypoxic 591±30 A 3,760±220 A 6,660±1,730 A,H 28,640±4,460 A 
Fetal Control 207±10 A 3,149±210 A 17,510±4995 A,V 6,037±636 A,I 
 VEGF 211±14 A 3,339±296 A 6,541±2506 A,V 7,264±887 A 
 VEGF+Vat 231±10 A 2,498±91 A 7,279±1285 A 9,995±1,945 A,I 
Adult Control 469±21 A 4,742±204 A 30,756±7685 A,V 8,167±1,773 V 
 VEGF 501±26 A 4,645±270 A 15,192±3737 A,V,I 4,479±1,260 V,I 
 VEGF+Vat 478±22 A 4,754±206 A 25,475±7876 A,V 6,990±1,197 V 
 
Medial thicknesses were measured in unfixed specimens using phase contrast light 
microscopy. Unstressed diameters were measured in arteries mounted in vitro for 
contractility. Stretch-dependent maximum (myogenic) stresses and maximum active 
stresses induced by exposure to isotonic Krebs buffer containing 122 mM K+ were 
averaged across arteries independent of the strain at which the maximum was observed. 
Note that the average of the maximum potassium-induced stresses (above) was greater than 
the maximum of the average potassium-induced stresses plotted against stretch-ratio in 
Figure 4. This difference implies that the stretch ratios at which maximum contractility was 
observed varied markedly among different segments. All normoxic and hypoxic values 
were obtained in freshly dissected arteries, whereas Control, VEGF, and VEGF+Vatalanib 
values were obtained in arteries organ cultured 48h. Indicated are means ± SEM for arteries 
from 8 normoxic fetuses, 4 hypoxic fetuses, 11 normoxic adults, and 8 hypoxic adults. The 
Control, VEGF, and VEGF+Vat means were calculated from 6 normoxic fetal lambs and 
11 normoxic adult sheep. Superscript A, H, V, and I denote significant differences (P<0.05) 
due to Age, Hypoxia, VEGF-treatment, and VEGFR Inhibitor-treatment. 
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Figure 1. Chronic Hypoxia Decreases Myogenic Contractility.  
Endothelium-denuded common carotid arteries harvested from fetal and adult sheep 
maintained at 3820 m for 110 days (Hypoxic) or at sea level (Normoxic) were used to 
determine stretch-induced myogenic stresses at different strains applied in increments of 
unstressed diameter (D/D0). Myogenic stresses were calculated as the spontaneous stresses 
measured under resting conditions at each strain ratio (D/D0) minus the passive stresses 
measured after freezing in liquid N2 at the same strain ratio. Active potassium-induced 
stresses were induced by exposure to isotonic Krebs buffer containing 122 mM K+. The 
potassium-induced stresses were calculated as the maximum stresses measured during 
exposure to high potassium at each strain ratio (D/D0) minus the spontaneous stresses 
measured under resting conditions at the same strain ratio. Note that spontaneous myogenic 
stresses were greater in fetal than adult arteries (upper panels), whereas active potassium-
induced stresses were less in fetal than adult arteries (lower panels). Error bars indicate 
SEM for arteries from 8 normoxic fetuses, 4 hypoxic fetuses, 11 normoxic adults, and 8 
hypoxic adults. The * denotes significant differences between normoxic and hypoxic 
values at P<0.05. 
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Figure 2. Chronic Hypoxia Alters Myosin Heavy Chain Abundance and Distribution. 
Coronal sections of endothelium-denuded carotid arteries from normoxic (N) and hypoxic 
(H) fetal and adult sheep were immunostained for Non-Muscle Myosin Heavy Chain (NM-
MHC) or Smooth Muscle Myosin Heavy Chain (SM-MHC). Cell nuclei were stained with 
DAPI (blue). In the left panel are representative matched sections from a single animal for 
NM-MHC and SM-MHC. Whole artery abundance of each MHC was quantified via 
immunoblot and MHC distribution between the luminal and adventitial margins of the 
medial layer was determined by line scans of the images. Regions within the artery wall 
were defined as Inner (area just inside basal elastic lamina), Middle (area midway between 
basal elastic lamina and adventitial-medial border), and Outer (medial area immediately 
adjacent to the adventitial-medial border). Each individual MHC isoform differed 
significantly between normoxic and hypoxic arteries as denoted by asterisks on the figure 
(P<0.05). MHC abundances varied significantly (P<0.05) among the different intramural 
regions only in fetal arteries. Vertical error bars represent standard errors for n≥5 for all 
groups. 
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For SM-MHC, relative abundance was significantly less in fetal than in adult arteries; 
fetal values averaged only 62% of adult values in normoxic arteries, and only 17% of 
adult values in hypoxic arteries. Hypoxia significantly decreased SM-MHC abundance to 
60% of normoxic values in fetal arteries but increased it to 223% of normoxic values in 
adult arteries. Distribution was homogenous among all artery wall regions in all four 
treatment-age groups (Figure 2).  
 
Hypoxia Altered Colocalization of MHC Isoforms and SM -Alpha Actin 
Consistent with the abundance results, colocalization of NM-MHC with SM-AA 
in normoxic fetal arteries averaged 1,820% of colocalization in normoxic adult arteries 
(Figure 3), and in hypoxic fetal arteries averaged 880% of colocalization in hypoxic 
adult arteries; maturation markedly decreased NM-MHC colocalization. Hypoxia 
depressed NM-MHC colocalization to 52% of normoxic values in fetal arteries (P<0.05), 
but was without effect in adult arteries (Figure 3). 
Although SM-MHC abundance was significantly less in fetal than adult arteries 
(Figure 2), colocalization of SM-MHC with SM-AA was greater in fetal than adult 
arteries. SM-MHC and SM-AA colocalization also was not affected by chronic hypoxia 
in fetal arteries, but was decreased by hypoxia in adult arteries. Colocalization values in 
normoxic fetal arteries were 220% of values in normoxic adult arteries, and in hypoxic 
fetal arteries colocalization averaged 390% of hypoxic adult arteries (Figure 3). 
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Effects of VEGF and VEGF Receptor Antagonism on Age-Dependent 
Contractility  
To assess the potential role of VEGF in hypoxic vascular remodeling, the effects 
of VEGF on vascular contractility were determined in a separate series of arteries 
cultured in the presence and absence of the VEGF receptor antagonist vatalanib (Figure 
4) (35).  Medial wall thicknesses and unstressed diameters were significantly less in fetal 
than adult arteries in each treatment group and did not vary with treatment in either age 
group (Table 1). 
Maximum stretch-dependent stresses averaged less in fetal than adult arteries in 
all three treatment groups (Table 1). In fetal arteries, maximum stretch-dependent 
stresses in VEGF-treated and VEGF+vatalanib treated arteries were only 37% and 42% 
of control values, respectively (P<0.05) and did not differ from one another. In adult 
arteries, maximum stretch-dependent stresses in VEGF-treated arteries were 49% of 
control whereas these values in the VEGF+vatalanib groups were 83% of control; 
vatalanib prevented the effects of VEGF such that stretch-dependent stresses in the 
VEGF+vatalanib group were similar to the control group. 
Maximum K+-induced stresses in fetal and adult arteries were similar in the 
control group, but in the VEGF and VEGF+vatalanib groups, fetal values were 
significantly greater than adult values (Table 1). In fetal arteries, stresses in VEGF and 
VEGF+vatalanib treatment groups were 120% (NS) and 166% (P<0.05) of control 
values, respectively, and did not differ from one another. In adult arteries, average 
stresses in the VEGF and VEGF+vatalanib groups were 55% (P<0.05) and 86% (NS) of 
control values; in adult arteries vatalanib prevented the effects of VEGF such that stretch-
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dependent stresses in the VEGF+vatalanib group were significantly greater than in the 
VEGF group and were similar to the control group. 
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Figure 3. Hypoxia and Age Modulate Colocalization of Myosin Heavy Chain Isoforms 
with Smooth Muscle-Alpha Actin. 
Coronal sections of endothelium-denuded carotid arteries from normoxic and hypoxic fetal 
and adult sheep were immunostained for myosin heavy chain isoforms NM-MHC or SM-
MHC (red) and Smooth Muscle-Alpha Actin (SM-AA, green). Colocalizations of SM-AA 
with myosin heavy chain isoforms are displayed in the merged images (yellow). 
Colocalization of NM-MHC with SM-AA was significantly greater in fetal than in adult 
arteries and was also less in hypoxic than in normoxic fetal but not adult arteries. 
Colocalization of SM-MHC with SM-AA was significantly greater in fetal than in adult 
arteries and was also less in hypoxic than normoxic adult but not fetal arteries . Asterisks 
(*) indicate significant effects of hypoxia at P<0.05 for N≥ 4 in each group. Error bars 
indicate standard errors. 
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Figure 4. The VEGF Receptor Inhibitor Vatalanib Ablates the Effects of VEGF. 
Endothelium-denuded carotid arteries from 6 normoxic fetal lambs and 11 normoxic adult 
sheep were serum starved for 24h then cultured another 24h under starvation conditions 
(Control), with 3 ng/ml VEGF (VEGF), or with 3 ng/ml VEGF + 240 nM vatalanib 
(VEGF+vatalanib). With this approach, all arteries underwent a standardized organ culture 
regiment with treatments between groups varying only by the presence or absence of VEGF 
and/or vatalanib. Following organ culture, stress-strain relations were determined; at each 
level of strain examined both stretch dependent myogenic stress (upper panels), and the 
active response to depolarization with 122 mM potassium (lower panels) were determined. 
VEGF decreased stretch-dependent stresses in both fetal and adult arteries, but decreased 
potassium-induced stresses only in adult arteries. Vatalanib prevented the effects of VEGF 
on myogenic and active stresses only in adult arteries. Asterisks denote significant 
differences between control and VEGF treatment at P<0.05 (Behrens Fisher). Error bars 
indicate SEM for the N values given in Table 1. 
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Effects of VEGF on Age-Dependent MHC Abundance and Distribution 
To explore the effects of serum starvation alone on MHC isoform expression, 
abundances in normoxic fresh, uncultured arteries (Figure 2) were compared to 
corresponding values in serum-starved control arteries (Figure 5). These comparisons 
revealed that in contrast to the marked effects of serum starvation on the abundance of 
other contractile proteins such as MLCK (11), serum starvation had only modest effects 
on the abundance of MHC isoforms in both fetal and adult arteries. To control for these 
changes, all effects of VEGF were determined by comparisons between “starved” and 
“VEGF-treated” segments. With this approach, all arteries underwent a standardized 
organ culture regiment with treatments between groups varying only by the presence or 
absence of VEGF and/or vatalanib. 
The relative abundance of NM-MHC in control and VEGF-treated fetal arteries 
was 1,960% and 1,740% of abundance in corresponding adult arteries (Figure 5). VEGF 
treatment increased NM-MHC abundance in fetal arteries, but this effect was significant 
only in the inner medial region. VEGF had no significant effect on NM-MHC abundance 
in adult arteries. In control fetal arteries, the local abundance (in µg / µg standard) of 
NM-MHC was significantly greater in the inner medial region (5.35 ± 0.78) than in the 
middle medial region (3.88 ± 0.55), which in turn was greater than in the outer medial 
(2.54 ± 0.37) region (Figure 5). A similar pattern was observed across the inner medial 
(6.64 ± 0.53), middle medial (4.43 ± 0.36) and outer medial (2.99 ± 0.22) regions of 
VEGF-treated fetal arteries. In adult arteries, NM-MHC abundances did not vary 
significantly among regions in either control or VEGF-treated arteries. 
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For SM-MHC, the relative abundances were significantly less in control fetal than 
in control adult arteries. VEGF treatment did not significantly influence abundances of 
SM-MHC in either fetal or adult arteries, and these abundances remained significantly 
less in VEGF-treated fetal than in VEGF-treated adult arteries (Figure 5). Regional 
abundances of SM-MHC did not vary significantly across the different transmural 
regions in control or VEGF-treated arteries from either age group. 
 
VEGF Altered Colocalization of MHC with SM-Alpha Actin 
Colocalization of NM-MHC with SM-AA in control fetal arteries averaged 710% 
of control adult arteries (Figure 6). VEGF treatment reduced NM-MHC colocalization to 
only 32% and 36% of control values in fetal and adult arteries, respectively. After VEGF 
treatment, NM-MHC colocalization remained markedly greater in fetal than adult 
arteries. 
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Figure 5. Effects of VEGF on Myosin Heavy Chain Abundance and Distribution. 
Endothelium-denuded carotid arteries from 6 normoxic fetal lambs and 6 normoxic adult 
sheep were serum starved for 24h and then were cultured an additional 24h in the presence 
or absence of 3 ng/ml VEGF. Following organ culture, the arteries were processed for 
immunostaining as described for Figure 2. Organ culture with VEGF did not significantly 
(P<0.05) alter abundance for either MHC isoform except a modest increase of NM-MHC 
with VEGF in the inner medial region of fetal arteries (*). In both control and VEGF-
treated fetal arteries, NM-MHC exhibited a gradient in which abundance was greatest in 
the inner medial layer and least in the outer medial layer. Shown are means and standard 
errors for N=6 for all groups.  
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Figure 6. VEGF Alters Colocalization of Myosin Heavy Chain Isoforms with Smooth 
Muscle-Alpha Actin.  
Coronal sections of endothelium-denuded carotid arteries from 6 normoxic fetal and 6 
normoxic adult sheep were immunostained following organ culture with or without VEGF 
as described for Figure 3. Colocalizations of SM-AA (green) with myosin heavy chain 
isoforms are displayed in the merged images (yellow) for the NM-MHC and SM-MHC 
isoforms (red).  Colocalization of NM-MHC with SM-AA was significantly decreased by 
VEGF only in fetal arteries (*). Colocalization of SM-MHC with SM-AA was significantly 
decreased by VEGF only in adult arteries (*). Statistical significance implies P<0.05. 
Vertical error bars indicate standard errors for n≥5 for all groups. 
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Colocalization of SM-MHC with SM-AA was similar in control fetal and control 
adult arteries. VEGF treatment had no significant effect on SM-MHC colocalization in 
fetal arteries, but decreased colocalization significantly to 40% of control values in adult 
arteries. After VEGF treatment, SM-MHC colocalization in fetal arteries was 260% of 
colocalization in adult arteries. 
 
Discussion 
The present study offers six original observations in endothelium-denuded carotid 
arteries. First, hypoxic acclimatization depressed stretch-dependent contractions much 
more than K+-induced contractions in both fetal and adult arteries. Second, hypoxic 
acclimatization increased abundances of NM-MHC in fetal and adult arteries but 
increased SM-MHC only in adult arteries. Third, hypoxic acclimatization decreased the 
colocalization of NM-MHC with SM-AA only in fetal arteries but decreased 
colocalization of SM-MHC with SM-AA only in adult arteries. Fourth, similar to 
hypoxia, organ culture with 3 ng/ml VEGF depressed stretch-dependent and K+-induced 
contractions in both adult and fetal arteries. Fifth, unlike hypoxia, organ culture with 
VEGF induced few significant changes in MHC abundance in either fetal or adult 
arteries. Sixth, like hypoxia, organ culture with VEGF decreased the colocalization of 
NM-MHC with SM-AA in fetal arteries and decreased colocalization of SM-MHC with 
SM-AA in adult arteries. Together, these observations support the hypothesis that VEGF 
may contribute to age-dependent hypoxic remodeling of artery structure and function 
through changes in contractile protein abundance and organization secondary to changes 
in smooth muscle phenotype. 
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Hypoxic Acclimatization Altered Artery Structure and Function 
The effects of hypoxic acclimatization on artery wall thicknesses vary with artery 
type, size, and age (38, 60, 68) and can differentially affect the endothelial, medial and 
adventitial layers (59, 67). To better understand the functional consequences of hypoxic 
changes in artery structure, the present study focused on the medial layer that contains the 
smooth muscle cells responsible for contractile force. In both adult and fetal ovine carotid 
arteries, hypoxic acclimatization had no significant effect on medial thicknesses, which 
suggests that any changes in artery contractility induced by hypoxia must have been due 
to changes in either the abundances or organization of contractile proteins within the 
arterial smooth muscle. 
In many vascular studies, contractile responses are measured only in units of 
grams or as percentages of responses to a standard contractant such as high potassium at 
a single segment length or passive tension. These approaches can provide excellent 
internal normalization but do not account for differences in wall thickness, contractile 
protein content, stiffness, or optimum length, which can be significant when comparing 
contractility across different chronic treatment groups. To avoid these limitations, our 
experimental approach included complete stress-strain determinations for each segment 
in which contractile responses were quantified as changes in active stresses measured in 
units of force per medial cross-sectional area at multiple levels of arterial strain, as 
previously described (11). Consistent with earlier findings, these measurements revealed 
(Figure 1) that K+-induced contractions were greater in adult than fetal arteries (11), and 
were not dramatically attenuated by hypoxia (38). In contrast, stretch-dependent 
(myogenic) contractions were of greater magnitude in fetal than adult arteries but were 
 51 
similarly and significantly attenuated by hypoxic acclimatization in both age groups 
(Table 1). This disconnect between the effects of hypoxia on K+-induced and stretch-
dependent (myogenic) contractions demonstrates that hypoxic acclimatization can 
differentially influence select components of the contractile apparatus and may 
preferentially affect mechanisms coupling stretch to contraction. Candidate mechanisms 
potentially involved in this selective effect of hypoxia include calcium channels involved 
in mechanotransduction (27) and contractile proteins involved in myogenic regulation of 
myofilament calcium sensitivity (14, 52). Interestingly, many of these mechanisms are 
strongly influenced by phenotypic transformation of smooth muscle (14, 29, 65). 
 
Hypoxic Acclimatization Altered MHC Abundance and Organization 
To explore the hypothesis that hypoxic changes in artery structure and 
contractility may be secondary to changes in smooth muscle phenotype, our experiments 
focused on changes in the abundance of MHC isoforms that are closely associated with 
both contractile capacity and smooth muscle phenotype (23, 24, 49). Because smooth 
muscle morphology and phenotype are highly heterogeneous in the artery wall (18, 60) 
our measurements of MHC abundance combined homogenate immunoblots calibrated 
against known standards, with radial line scans of fluorescent intensity in immunostained 
coronal sections to estimate regional protein abundance across the artery wall, as 
previously described (11). This approach revealed that the embryonic isoforms of MHC 
(NM-MHC), which are prevalent in functionally immature and proliferative smooth 
muscle cells (17, 44, 49), were more abundant in fetal than adult arteries, were more 
abundant in hypoxic than normoxic arteries in both age groups, and exhibited significant 
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regional variability with highest abundance near the lumen in fetal arteries (Figure 2). 
Together, these NM-MHC results support the hypothesis that hypoxia stimulates 
phenotypic transformation of arterial smooth muscle. The regionality of this effect in 
fetal arteries further suggests that vasotrophic factors released from the vascular 
endothelium, which was present and presumably functional in both normoxic and 
hypoxic fetal arteries before harvest, may influence intramural distribution and 
abundance of NM-MHC. Another possibility is that hypoxia stimulated changes in the 
expression of growth factor receptors on smooth muscle cells, and thereby enhanced 
regional heterogeneity in reactivity to vasotrophic factors with subsequent regional 
changes in contractile protein abundance. Although this lamellar heterogeneity could be a 
simple consequence of growth factor gradients with little functional significance, it seems 
more likely that this heterogeneity is an important feature of arterial homeostasis that 
dynamically distributes roles for contractile function and secretory function throughout 
the smooth muscle cells of the artery wall. 
Whereas the NM-MHC isoforms of myosin heavy chain are coded by at least 
three different genes, the other primary isoforms of smooth muscle myosin (SM-MHC) 
arise from a single gene (17). More importantly, the contractile characteristics of the NM-
MHC and SM-MHC isoforms of MHC differ significantly from one another. 
Correspondingly, NM-MHC appears more commonly in functionally immature smooth 
muscle, and SM-MHC is more common in fully differentiated contractile smooth muscle 
(7, 17, 44). Consistent with this pattern, the abundance of the NM-MHC isoform was 
significantly greater in fetal than adult arteries. In addition, fetal and adult NM-MHC 
abundances were significantly increased by hypoxic acclimatization (Figure 2), 
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suggesting that hypoxia promoted either proliferation of non-contractile smooth muscle 
or stimulated dedifferentiation of fully differentiated contractile smooth muscle. Both of 
these mechanisms would help explain the observed hypoxic attenuation of contractility 
(Figure 1).  
Consistent with the relevant literature (31, 44, 49), the overall abundance of the 
SM-MHC isoform was markedly less in fetal than in adult arteries, which helps explain 
the greater peak contractile responses to potassium in adult compared to fetal arteries 
(Figure 1, lower panels). Relative to normoxic abundances of SM-MHC, chronic 
hypoxia significantly increased SM-MHC in adult arteries, but reduced SM-MHC in fetal 
arteries (Figure 2). As might be expected, the hypoxic decrease in SM-MHC abundance 
in fetal arteries was associated with decreased contractility (Figure 1). In contrast, the 
large hypoxic increase in SM-MHC abundance in adult arteries was also associated with 
decreased contractility, suggesting that simple abundance of SM-MHC is not a primary 
determinant of contractile capacity. 
How hypoxic acclimatization selectively altered MHC isoform abundances 
remains uncertain but could be explained by either age-dependent hypoxic release of 
trophic factors or by increases in sensitivity to those factors. Whatever the nature of those 
factors, their effects on SM-MHC were uniform across the artery wall in both fetal and 
adult arteries, suggesting that these factors did not originate exclusively from either the 
luminal or adventitial border of the medial layer. Overall, these results are consistent with 
previous reports that hypoxia can increase total MHC content (70), and also support the 
hypothesis that the artery wall contains smooth muscle in multiple phenotypic states with 
varying responses to trophic and mitogenic stimuli (24, 56, 69). These results, however, 
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do not help explain hypoxic attenuation of contractility: how is it possible that hypoxia 
increased the content of SM-MHC but decreased contractility? Clearly, factors other than 
MHC abundance must be involved. 
Smooth muscle contraction requires the interaction between myosin and smooth 
muscle-Alpha Actin. SM-AA is a smooth muscle marker protein expressed in both 
immature non-contractile and fully differentiated contractile smooth muscle (25, 44). 
SM-AA abundance increases during maturation of contractile capacity (45) and also 
increases during hypoxic acclimatization (54). Because hypoxia can increase both SM-
AA and MHC but simultaneously decrease contractile capacity, some aspect of the 
interaction between SM-AA and MHC must be affected by hypoxia. Whereas possible 
changes in numerous other smooth muscle proteins (59) might influence calcium 
handling, calcium sensitization, myosin phosphorylation or cytoskeletal organization, 
virtually all of these mechanisms act by altering the activation of regulatory myosin light 
chain or its access to filamentous actin (57). Another possibility is that the spatial 
organization of MHC relative to SM-AA is altered as a consequence of structural 
responses to hypoxic acclimatization. To test this hypothesis, our experimental approach 
included measurements of the fraction of SM-AA colocalized with both of the main 
MHC isoforms using confocal microscopy as previously described (14). Colocalization 
of NM-MHC with SM-AA was significantly decreased by hypoxia in fetal arteries, but 
was unchanged in adult arteries (Figure 3) due perhaps to the very low content of NM-
MHC in mature arteries. Conversely, colocalization of SM-MHC with SM-AA was 
decreased by hypoxia in adult but not fetal arteries. These results are consistent with the 
hypothesis that hypoxia promotes the fraction of synthetic smooth muscle cells in the 
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artery wall. In the fetus, hypoxia increased NM-MHC, decreased SM-MHC, and 
decreased colocalization of NM-MHC with SM-AA. These changes, together with no 
significant change in medial thickness (Table 1) and decreased contractility (Figure 1), 
strongly suggest that in fetal arteries hypoxic acclimatization promoted a shift in smooth 
muscle characteristics toward a less contractile, more proliferative, more synthetic 
phenotype. In adult arteries, hypoxic acclimatization increased NM-MHC but also 
increased SM-MHC while decreasing colocalization of SM-MHC with SM-AA. The 
simultaneous increase in SM-MHC abundance with a decrease in SM-MHC 
colocalization with SM-AA suggests increased rates of contractile protein synthesis 
together with possible disassembly of the contractile apparatus. Again, these changes 
together with no significant change in medial thickness (Table 1) and decreased 
contractility (Figure 1), strongly suggest that in adult arteries hypoxic acclimatization 
also promoted a shift in smooth muscle characteristics toward a less contractile, more 
proliferative, more synthetic phenotype.  
 
VEGF Altered Artery Structure and Function 
Aside from the effects of hypoxic acclimatization on the abundance and 
organization of vascular contractile proteins and the corresponding changes in contractile 
capacity, it remains uncertain how chronic hypoxia might bring about such changes. One 
possibility is that VEGF may be involved. Secondary to hypoxic increases in HIF-1 
release (53), hypoxia stimulates the synthesis and release of VEGF, which promotes 
angiogenesis (28, 40) but can also exert trophic influences on many non-endothelial cell 
types including retinal pericytes (61), neurons (32), astrocytes (22), peripheral neurons 
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and Schwann cells (39, 58), skeletal muscle (9), and most importantly, smooth muscle 
(11, 26, 43). To test the hypothesis that VEGF may contribute to hypoxic vascular 
remodeling, our experimental approach compared the effects of hypoxic acclimatization 
to the effects of organ culture with 3 ng/ml VEGF. This approach avoided the smooth 
muscle dedifferentiation typical in cultured smooth muscle (63) and preserved the three-
dimensional structure of the artery wall required for colocalization studies. Our 3 ng/ml 
concentration of VEGF was similar to the physiological concentrations of 2 ng/ml 
reported in pregnant sheep (64) but was far less than the 40-50 ng/ml concentrations used 
in other studies of VEGF (5, 13), which helped minimize possible cross-activation of 
PDGF receptors that can occur at VEGF concentrations of 10 ng/ml or greater (4). To 
avoid the dedifferentiating effects caused in smooth muscle by exposure to fetal bovine 
serum (34, 51), the organ cultures did not include FBS. Although organ culture can alter 
the abundances of some contractile proteins (11), such effects should similarly influence 
both stretch-dependent and K+-dependent contractions; these were measured in the same 
arteries. Because organ culture affected stretch-dependent and K+-dependent contractions 
very differently (Figure 1 Normoxic vs. Figure 4 Control), the results suggest that organ 
culture alters contractility through mechanisms other than just changes in contractile 
protein abundance.  Given that peak contractile stresses independent of method of 
contraction were similar in fresh and organ cultured arteries, overall contractility was 
optimally preserved as previously described (11).  
Similar to the effects of hypoxic acclimatization on contractility, organ culture 
with VEGF significantly decreased overall contractility in both fetal and adult arteries 
(Figure 4). In adult arteries this effect of VEGF was prevented by vatalanib, a mixed 
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VEGF-R1/R2 antagonist (35) at a concentration (240 nM) validated to be optimal in this 
preparation. Vatalanib had no effect on VEGF-induced depression of contractility in fetal 
arteries. Together, these findings suggest that VEGF acts through VEGF-R1/R2 receptors 
to attenuate both stretch-dependent and K+-induced contractions in adult arteries. In fetal 
arteries, VEGF must act through a different pathway to influence contractility. The 
unique effects of VEGF on fetal arteries might possibly involve altered coupling of 
VEGF receptors to cytosolic kinases (42), but might also potentially involve activation of 
PDGF receptors (4) which are highly abundant in immature arteries (2); more 
experiments were required to differentiate among these possibilities. Together, these 
results are consistent with the hypothesis that VEGF may contribute to hypoxic vascular 
remodeling through transformation of smooth muscle phenotype, but also emphasize that 
the mechanisms involved must be very different in fetal and adult arteries. 
 
Effects of VEGF on MHC Abundance and Organization 
The general effects of VEGF on NM-MHC abundance were roughly similar to the 
effects of chronic hypoxia (Figure 5, upper right), although the effects of VEGF were 
more modest due perhaps to the low concentration of VEGF employed. As in normoxic 
fetal arteries, NM-MHC exhibited a graded decrease in abundance from the inner medial 
region to the outer medial region suggesting a possible regional influence from the 
vascular endothelium. For SM-MHC abundance however, VEGF did not reproduce the 
effects of hypoxic acclimatization and was without effect on either the abundance or the 
homogeneous distribution of SM-MHC throughout the media in both fetal and adult 
arteries. Despite its relative absence of effects on NM-MHC and SM-MHC, VEGF still 
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decreased contractility in fetal and adult arteries, again suggesting a shift toward a less 
contractile smooth muscle phenotype.  
In both fetal and adult arteries, hypoxia-induced changes in contractility were 
more closely associated with changes in contractile protein organization than with 
changes in abundance (Figure 1-3). To examine if VEGF-induced changes in 
contractility were similarly associated with changes in contractile protein organization, 
we examined the influence of VEGF on the spatial organization of MHC isoforms 
relative to SM-AA (Figure 6). For NM-MHC, VEGF treatment decreased colocalization 
with SM-AA in fetal but not adult arteries and thus replicated the qualitative effect of 
hypoxia. In addition, VEGF decreased colocalization of SM-MHC with SM-AA in adult 
but not fetal arteries, which also reproduced the pattern produced by hypoxia. These 
colocalization results further support the hypothesis that VEGF may contribute to 
hypoxic vascular remodeling, at least in the ovine carotid artery. These results also 
reinforce the interpretation that contractility was more consistently associated with 
contractile protein organization than with contractile protein abundance; both hypoxia 
and VEGF similarly decreased contractility as well as NM-MHC colocalization in the 
fetus and SM-MHC colocalization in the adult. In contrast, hypoxia and VEGF produced 
only increases in the abundance of NM-MHC and had inconsistent effects on SM-MHC. 
Another approach to compare the effects of hypoxic acclimatization and treatment 
with VEGF arises from the presumed obligatory relation between contractile protein 
abundance and organization. A protein can be colocalized with another protein only if 
both proteins have been synthesized and are present near one another. In other words, 
colocalization is limited by regional abundance. If colocalization is merely a stochastic 
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process, then increased abundance of any protein should increase its colocalization with 
its binding partners. To test this idea, our data analysis compared parallel changes in 
abundance and colocalization following treatments with both hypoxia and VEGF. 
Altogether, these comparisons strongly suggested that the observed changes in 
colocalization were not simply secondary to increased abundance; in almost all instances 
the changes in abundance and colocalization were not directly proportional. This latter 
finding implies that both hypoxia and VEGF have significant and parallel effects on the 
abundances, trafficking and localization of contractile proteins within arterial smooth 
muscle cells. The mechanisms mediating these effects are uncertain, but could involve 
changes in cytoskeletal remodeling, microtubular transport, or protein-protein 
interactions as suggested in other cell types (3). Thus, the present results follow a major 
trend in contemporary cell biology that is focused on the complex and unidentified 
mechanisms that govern subcellular protein distribution, trafficking, and localization. 
Independent of mechanisms governing abundance and colocalization of smooth 
muscle contractile proteins, both hypoxia and VEGF appeared to recruit some of these 
mechanisms similarly. VEGF reproduced some, but not all, of the effects of hypoxic 
acclimatization, suggesting that factors other than VEGF must be involved in hypoxic 
vascular remodeling, particularly in relation to regulation of SM-MHC abundance. 
Conversely, hypoxia and VEGF had much more similar effects on colocalization of the 
MHC isoforms with SM-AA in both fetal and adult arteries (Figures 3 and 6). 
Interestingly, this close parallel between hypoxia and VEGF in relation to MHC 
colocalization was observed, even though VEGF may not signal through traditional 
VEGF receptor-dependent pathways in fetal arteries (Figure 4). This concurrence of 
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effects of hypoxic acclimatization and VEGF on MHC colocalization strongly supports 
the main hypothesis that VEGF may contribute to hypoxic vascular remodeling in both 
fetal and adult arteries. 
 
Overview 
Together, the results of the present study demonstrate that hypoxic 
acclimatization and VEGF exert both common and independent effects on contractility, 
MHC isoform abundance, and MHC-SM-AA organization. In light of abundant evidence 
that hypoxia increases both VEGF (36, 37) and VEGF receptor density (8), the present 
findings suggest that hypoxic acts through VEGF not only to increase capillary density 
(28), but also to mediate remodeling of arterial smooth muscle (Figure 7). The present 
results further emphasize that VEGF can act directly on vascular smooth muscle through 
receptor-dependent pathways that appear to involve VEGF-R1/R2 in adult but not fetal 
arteries; this difference may help explain many of the observed age-related differences in 
responses to both hypoxia and VEGF.  Together, these results also give rise to the 
hypothesis that smooth muscle phenotype is a determinant of the responses to hypoxia 
and VEGF, and that one component of these responses may be to stimulate phenotypic 
conversion and thereby alter contractile protein abundance, organization, and function. 
On the other hand, differences in responses to hypoxia and VEGF emphasize that VEGF 
is not the only or perhaps even most important vasotrophic factor contributing to hypoxic 
vascular remodeling. Many important questions remain: what other factors contribute; 
what receptors mediate fetal responses to VEGF; might larger concentrations of VEGF 
applied for longer durations produce greater or different effects; what mechanisms 
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govern MHC colocalization independent of abundance? Aside from these and other 
questions for future investigations, the present results support the hypothesis that VEGF 
may contribute to hypoxic vascular remodeling in an age-dependent manner through 
effects that involve changes in MHC abundance, organization, and function. 
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Figure 7. Hypoxic Vascular Remodeling Involves VEGF-Dependent and VEGF-
Independent Effects on Contractile Protein Abundance and Organization. 
Hypoxia can influence arterial structure and function through VEGF-independent and 
VEGF-dependent pathways. VEGF-dependent effects appear to be mediated in adult 
arteries through activation of VEGF receptors, with corresponding changes in MHC 
organization but not abundance (Pathway 1). In fetal arteries, VEGF appears to alter MHC 
abundance and organization independent of VEGF receptors (Pathway 2). Given that 
VEGF alone did not produce the full spectrum of hypoxic effects, hypoxia must also exert 
VEGF-independent effects on contractile protein abundance and organization (Pathway 3). 
Overall, the effects of hypoxia on MHC abundance and organization appear to be 
independently regulated. Equally important, changes in contractile protein organization 
were more tightly associated with changes in contractility than were changes in abundance. 
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Introduction  
Fetal cerebral angiogenesis is a complex and delicate process. As such it is 
vulnerable to numerous stressors, not the least of which includes acute and chronic 
hypoxia. This hypoxic stress is often due to placental insufficiency, pre-eclampsia, 
gestational diabetes, maternal nicotine use, and more.  The response to hypoxic stress 
may involve vascular remodeling that includes alterations to vascular structure and 
function as well as a predisposition to cardiovascular disease in adulthood and a long-
term maladaptation to subsequent hypoxic insults.  
Hypoxic vascular remodeling is mediated by numerous growth factors, cytokines, 
miRNAs, and notably Vascular Endothelial Growth Factor (VEGF).  VEGF has been 
shown to act on multiple cell types including endothelium, smooth muscle, neurons, and 
more. VEGF also activates several known signaling pathways, including the nitric oxide 
(NO) pathway, that induce short-term changes in arterial function (vasorelaxation) as 
well as long-term changes in the smooth muscle cell (SMC) phenotype. These changes 
include a transition in the expression and organization of alpha actin and myosin heavy 
chain.  VEGF is one of numerous stimuli that activate the release of NO within the 
endothelium in response to stress. NO released from the endothelium rapidly diffuses into 
the adjacent vascular smooth muscle (VSM) where it serves as a paracrine signal to 
promote vasorelaxation.  
The main endpoint of the NO pathway is the cGMP-dependent protein kinase 
(PKG). PKG is pleiotropic; it (PKG) has literally hundreds of known kinase targets, and 
displays a variety of well-studied activities depending on the specific tissue type wherein 
it is activated.  In vascular smooth, activation of PKG has been shown to promote the 
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expression of contractile proteins and alter the VSM phenotype.  Likewise, VEGF is 
shown to act directly via FLT-1 and KDR receptors, and indirectly through the NO, and 
possibly other pathways to alter the VSM phenotype. This represents a long-term shift in 
the character and behavior of the cerebral VSM, and alters the response to any 
subsequent stress including hypoxic challenge.  Our main hypothesis is that chronic 
hypoxia modulates the influence endothelial modification of VSM function and 
phenotype in part through changes in response to VEGF and the NO pathway.  
Specifically, this hypothesis predicts that hypoxic acclimatization 1) alters the 
endothelium and its modulation of contractile protein organization and smooth muscle 
function, 2) that the endothelial response to exposure to VEGF is altered and 3) that 
hypoxic alterations to the endothelial and smooth muscle cell occurs in part through a 
change in the NO-PKG pathway. To test our hypothesis, we performed organ culture 
using intact and denuded fetal and adult middle ovine cerebral arteries (MCAs). To 
examine the influence of the NO pathway, we inhibited NO production by eNOS with L-
NAME. Our main endpoints included a functional assay, length-tension protocol 
measuring myogenic tone and passive stretch using an isometric force transducer. We 
also examined changes in the VSM phenotype by measuring colocalization of SM-alpha 
Actin (SM-αA) with two myosin heavy chain (MHC) isoforms using confocal 
microscopy.   
In the context of this study, artery “structure” was assessed through measurements 
of medial layer thickness, artery stiffness, and intracellular organization of smooth 
muscle contractile proteins. In turn, intracellular organization and smooth muscle 
phenotype were defined by the patterns of colocalization of Non-Muscle and Smooth 
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Muscle MHC with SM-αA into 3 distinct quadrants (21, 22). Quantification of various 
contractile and smooth muscle protein markers is well established in the literature to 
characterize smooth muscle phenotype. Our lab has further extended this method of 
identification by use of immunohistochemical colocalization among these markers, which 
yields a better correlation to contractile function than mere protein abundance (1, 5, 10). 
In this study we applied this colocalization method to identify shifts among smooth 
muscle phenotypes with 3 primary mechanistic perturbations: denudation of the 
endothelium, vasotrophic stimulation by VEGF in organ culture and inhibition/activation 
of the NO-PKG pathway. We introduce a novel quartile method to demonstrate shifts 
among smooth muscle phenotypes using established MHC isoform colocalization with 
SM-αA to distinguish fully differentiated contractile from partially de-differentiated and 
fully de-differentiated (synthetic, migratory, proliferative) SMC phenotypes. The 
experimental design focused first on the effects of chronic hypoxia on artery structure 
and function in the presence and absence of the endothelium using established methods 
for measurements of in vitro contractility and confocal microscopy (5, 6) These same 
endpoints are utilized to define the structural and functional effects of acute organ culture 
with VEGF in a second set of experiments. Upon demonstrating that colocalization of 
multiple smooth muscle markers is the most sensitive indication of phenotype, we then 
perturbated the intercellular pathway of NO production and release by the endothelium 
by L-NAME to the smooth muscle and use confocal microscopy to characterize shifts 
within these phenotypic profiles. The effects of chronic hypoxia were examined by 
comparing arteries harvested from sheep maintained at sea level versus those maintained 
at high altitude (3820 m) for 110 days as previously described (19). Together, these 
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approaches enable a unique perspective on the role of the endothelium in directing 
smooth muscle phenotype and contractile function after hypoxic acclimatization as well 
as secondary exposure to VEGF. 
  
Materials and Methods 
 All procedure used in these studies were approved by the Animal Research 
Committee of Loma Linda University, adhered to the policies and practices set forth by 
the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and 
have been previously described in detail (5, 26). 
 
Tissue Harvest and Preparation 
Middle cerebral arteries were harvested using sterile techniques from fetal (139–
142 days gestation) sheep that had been maintained at either sea level (normoxic) or at 
3,820 m for the final 110 days of gestation (hypoxic). For tissue harvest, pregnant ewes 
were anesthetized with 10mg/kg ketamine and 5mg/kg midazolam, intubated, and then 
placed on 1%-2% isoflurane. The fetus was then exteriorized through a midline vertical 
laparotomy and euthanized by rapid removal of the heart and exsanguination. Harvested 
arteries were placed in sterile HEPES buffer solution containing the following (in mM): 
122 NaCl, 25.0 HEPES, 11.1 dextrose, 5.15 KCl, 2.40 MgSO4, 1.6 CaCl2, and 0.050 
EDTA. Following gentle removal of extracellular and loose connective tissue, one middle 
cerebral artery (MCA) was mechanically denuded of endothelium with the passage of a 
stainless steel rod through the lumen while the contralateral MCA remained endothelium 
intact as previously described (26). Both the intact and denuded artery were cut into 
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coronal segments 2–3 mm in length and then distributed to the various protocols. 
 
Organ culture 
As described previously (5), artery segments designated for organ culture were 
maintained in 12-well plates with DMEM (Sigma-Aldrich, St. Louis, MO; no. M56469C) 
supplemented with the following: 0.5% amino acid solution (Sigma Aldrich; no. M5550), 
1% nonessential amino acid solution (Sigma Aldrich; no. M7145), 3.7 g/l Na2HCO3, 4 
mM glutamine (Sigma Aldrich; no.G7513), 2% antibiotic-antimycotic solution (GIBCO, 
Carlsbad, CA; no. 15240–096), and 70 μg/ml gentamycin (GIBCO; no. 15750–060). 
Cultures were maintained in a humidified incubator with 5% CO2 in room air at 37 °C. 
Matched artery segments were cultured in supplemented DMEM without FBS for the 
initial 24 h to prevent dedifferentiation in vitro. This was followed by an additional 24 h 
in media containing DMEM (control) and 0, 3, 10 or 30 ng/ml VEGF-A165.  Preliminary 
dose-finding studies at VEGF concentrations between 3–100ng/mL were performed to 
identify the optimal concentration for VEGF effects by functional contractility assays.   
The concentration of 10 ng/ml VEGF used for all further studies was chosen to simulate 
physiologic serum levels measured in pregnant sheep (25) as well as  to minimize 
nonspecific binding of VEGF to other receptors (3). Following organ culture, arteries 
were allocated for analysis via fluorescent immunohistochemistry or contractility studies. 
This second protocol to elucidate the effect of hypoxia on the endothelial NO-PKG 
pathway consisted of matched intact and denuded arteries underwent organ culture in 
Ctrl, 10 ng/ml VEGF, the eNOS inhibitor LNAME (100uM), or 10 ng/ml VEGF ± 
100uM LNAME. 
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Artery Structure and Contractility 
Artery segments designated for contractility measurement were mounted on wires 
in vitro between an isometric force transducer and a micrometer slide used to set artery 
diameters. Mounted segments were initially equilibrated for 30 min in calcium-replete 
Na+-Krebs buffer containing the following (in mM): 5.17 KCl, 2.56 dextrose, 2.49 
MgSO4, 1.60 CaCl2, 122 NaCl, 25.6 NaHCO3, 0.114 ascorbic acid, and 0.027 EGTA. 
Buffer pH was maintained at ≈7.4 with continuous bubbling of 95% O2-5% CO2 at 
physiologic ovine core temperature of 38°C. After initial equilibration, the unstressed 
artery diameter (D0) of each segment was measured at a passive tension of 0.03 g. 
Working diameters (D) were calculated for each artery segment based on its D0 at strain 
ratios of D/D0 = 1.5, 1.8, 2.1, 2.4, 2.7, 3.0, and 3.3. Contractile stresses in dynes per 
centimeter squared were recorded at each of these strain values, in increasing order under 
resting conditions to determine spontaneous myogenic stress and then followed by 
contraction in a high potassium buffer containing the following (in mM): 122 KCl, 11.1 
dextrose, 2.50 MgSO4, 1.60 ml CaCl2, 5.16 NaCl, 2.15 NaHCO3, 0.114 ascorbic acid, and 
0.027 EDTA. After K+-induced contractions had stabilized, arteries were returned to Na+-
Krebs buffer, allowed to relax, and then stretched to and equilibrated at the next highest 
stretch ratio. After the K+-induced contraction had been measured at the maximum 
D/D0 ratio of 3.3, the arteries were frozen in liquid nitrogen to rupture the cells and then 
incubated in a calcium free Na+-Krebs buffer containing 3 mM EGTA to chelate and 
therefore further inhibit any smooth muscle cell derived force through 
Ca2+ sequestration. The passive stress produced at each strain ratio used was then 
recorded in descending order. 
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Myogenic stresses were calculated as the spontaneous stresses measured under 
resting conditions at each strain ratio (D/D0) minus the passive stresses measured after 
freezing in liquid N2 at the same strain ratio. The potassium-induced stresses were 
calculated as the maximum stresses measured during exposure to high potassium at each 
strain ratio (D/D0) minus the spontaneous stresses measured under resting conditions at 
the same strain ratio. Arterial stiffness was determined using the relations between strain 
and passive stress, using curve fitting with Young’s monotonic exponential model to 
determine the coefficient of stiffness. All methods used to quantify contractility have 
been described previously in detail (5). 
 
Immunohistochemistry 
Matched artery segments were fixed in 4% neutral buffered electron microscopy-
grade paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA; no. 15713S) for 
24 h at 4°C. Fixed segments were dehydrated and grouped by animal, embedded in a 
paraffin block, which was then sectioned at 5 μm and mounted on slides. Sections were 
deparaffinized by Histo-Clear (National Diagnostic, Atlanta, GA; no. HS-200) and then 
rehydrated by decreasing concentrations of alcohol, and microwaved in a citrate buffer at 
pH 6.03 to retrieve antigenicity. Permeabilization. Blocking was performed by 0.1% 
Triton X-100 (Sigma Aldrich; no. T-8787) and 1% BSA (Santa Cruz Biotechnology, 
Santa Cruz, CA; no. SC-2323) in PBS. To quantify shifts in phenotype, artery sections 
were then probed with antibodies to reveal expression of NM-MHC, an established 
marker for incompletely differentiated, partially contractile/synthetic smooth muscle, and 
SM-MHC, an established marker for differentiated, contractile smooth muscle present in 
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increasing abundance with animal maturation (21, 22). As stated in previous studies 
(Butler et al, Hubbell et al), these antibodies were selective for vascular tonic smooth 
muscle (MHC-A family) and not phasic smooth muscle (MHC-B family) Ref. (9). 
Sections were exposed overnight to primary antibodies utilizing primary 
monoclonal mouse anti-sheep antibodies against SM-αA (Sigma-Aldrich; A5228, 1:400) 
and either polyclonal rabbit anti-human NM-MHC (CoVance, Princeton, NJ; PPR-445P) 
at 1:400 or polyclonal rabbit anti-bovine SM-MHC (Abcam, Cambridge, MA; ab53219) 
at 1:500. The following day, slides were washed for two 10-min cycles in PBS and 
incubated using the appropriate secondary antibody. The secondary antibody was a goat 
anti-rabbit-488 (Thermo Scientific, Rockford, IL; no. 35552 lot LI150311) at 1:400 to 
detect SM-AA and goat anti-mouse-633 (Thermo Scientific, Rockford, IL; no. 35512 lot 
QD217311) to detect MHC and then incubated in the dark for 2 hours at room 
temperature. To minimize photobleaching, slides were maintained in the dark during 
staining and washings phases. Slides underwent two additional 10-min cycles in PBS and 
were then coverslipped using SlowFade Gold anti-fade reagent with DAPI (Invitrogen, 
Carlsbad, CA; S36939) and stored until imaged. All slides were imaged with an Olympus 
FV1000 confocal microscope at an optical section thickness of 0.7 μm, a lateral 
resolution of 200 nm, and a numerical aperture of 18.  
 
Confocal Microscopy  
As described under the Immunohistochemistry section, matched artery segments 
were collected, prepared, and immunostained with the primary monoclonal antibody 
against SM-AA and a second primary antibody against one of the MHC isoforms. 
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Because SM-AA is considered selective to smooth muscle and it is present in all SMC 
phenotypes, each MHC isoform was colocalized relative to the abundance of SM-AA. 
Similarly, only the alpha isoform of actin is involved in smooth muscle contraction, 
changes in other actin isoforms that may be expressed in smooth muscle should have 
little influence on smooth muscle contractile function (16) 
The extent of colocalization between the MHC and SM-αA was determined using 
Colocalizer Pro (www.Colocalizer.com), which included the calculation of a modified 
Mander’s Coefficient independent of absolute marker intensities (14).  Following 
imaging as described fully in the Immunohistochemistry section, coronal sections were 
extracted from the parent images with a masking routine that eliminated background 
contributions to the measurement statistics with removal of pixels outside of the medial 
layer of the artery. For each pixel in a double-immunostained image, the MHC marker 
and SM-AA was automatically graded as: 1) below threshold of 5% maximum intensity; 
2) above threshold but less than 50% maximum intensity (Low Intensity); or 3) greater 
than 50% maximum intensity (High Intensity). All pixels above threshold for both 
markers were grouped into 3 categories: Low MHC and Low SM-AA, Low MHC and 
High SM-AA, and High MHC and High SM-AA. The total of all pixels above threshold 
for both markers was set as 100% with the number of pixels in each of the 3 categories 
calculated as a percentage of that total. These methods have previously been described in 
detail (2, 8, 10). 
 
Data analysis and statistics 
Contractile stresses were calculated as ratios of force per cross-sectional area, 
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with force measured as contractile tension in grams times the acceleration due to gravity. 
The cross-sectional area (segment length x wall thickness) was corrected for changes due 
to stretch as described previously (11, 18). With regard to confocal colocalization, all 
values were calculated among SM-αA positive pixels, and then the fractions of those 
pixels also positive for each of the MHC isoforms was determined. Adding the individual 
colocalization index values for each of the MHC isoforms yielded the total colocalization 
values. The group error was calculated as a pooled variance. Each statistical comparison 
was done using Behrens-Fisher comparison at the P<0.05 level. 
 
Results 
A total of 379 middle cerebral artery segments were harvested from 22 normoxic 
fetuses (FN) and 23 hypoxic fetuses (FH).  156 segments were used for functional 
contractility studies and 223 segments were used for confocal imaging. Throughout “n” 
denotes the number of animals not the number of segments used in each experiment. 
Statistical significance was defined at P < 0.05 for all assays, with all values given as 
means ± SEM. 
 
Chronic Hypoxia Alters VEGF-Induced Endothelial Influence on Contractile 
Function 
To assess how hypoxia in utero alters the endothelial and smooth muscle response 
to an acute secondary hypoxic insult, artery segments from normoxic and hypoxic 
animals were either denuded of endothelium or left intact and then cultured in the 
presence of VEGF at either 0, 3, 10, or 30 ng/mL for 24hrs (Figure 1). Significant 
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changes in artery structure did not occur over this short duration (medial wall thickness 
nor passive stiffness) but significant changes in contractile force did occur. Overall, 
hypoxia in utero reduced maximum stretch-induced stress compared with respective 
normoxic controls for both endothelium-intact and endothelium-denuded arteries. In 
normoxic arteries, secondary VEGF exposure after denudation of the endothelium 
resulted in an 89% increase in stretch-induced stress compared with endothelium-intact 
arteries. This effect via the endothelium was ablated in hypoxic arteries. Hypoxia in utero 
did not significantly alter maximum K+-induced stress but it did diminish with VEGF 
exposure in endothelium-denuded compared with endothelium-intact arteries for both 
normoxic (-44%) and hypoxic arteries (-43%).  
 
Chronic Hypoxia Alters Smooth Muscle Colocalization Pattern of MHC 
Isoforms and Alpha Actin 
To complement the contractile effects of hypoxia in utero on the endothelium and 
smooth muscle, the parallel effects on contractile protein organization were assessed 
using confocal microscopy. The extent of colocalization for two distinct MHC isoforms 
with SM-AA was quantified for baseline organization in arteries immediately after 
harvest from normoxic and hypoxic animals (Figure 2) and in matched arteries after 
exposure to VEGF in organ culture (Figure 3).  Only pixels for which both proteins were 
above a minimal threshold of 5% maximum intensity were analyzed and the total number 
of such pixels was defined as 100%. Using a second threshold of 50% of maximal 
intensity for each marker, these pixels were categorized into three groups: 1) both 
markers above threshold but below half-maximal intensity (Low/Low); 2) MHC was 
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above threshold but below half-maximal intensity and for SM-AA was greater than half-
maximal intensity (Low/High); and 3) both MHC and SM-AA were greater than half-
maximal intensity (High/High). The effects of hypoxic acclimatization on baseline 
contractile protein organization in smooth muscle by examining how hypoxia shifted the 
total pixels among these categories. Also note that by definition, the number of pixels in 
quadrant LL, LR, and UR were defined to combine as the total number of physiologically 
relevant pixels so that each quadrant is represented by the % of the total pixels it contains 
and is reported as the “Raw percentage” seen in the left side component of Figure 2 and 
Figures 4-6. Therefore, throughout this article, LL + LR + UR = 100% within a treatment 
group. A corollary to this is that when pixels are lost from one quadrant they are 
mathematically obligated to be gained by another quadrant. Therefore, the three ’s 
within a quadrant sum to a net zero or simply put  LL+  LR +  UR = 0% as seen in 
the middle column of Figure 2, 4, 5, and 6. Similarly, within a treatment group the LL 
+ LR + UR = 0% as seen in the far right column of Figures 2 and Figures 4-6. 
In normoxic sections dual stained for SM-MHC and a-Actin (Figure 2, Left 
Panel), pixels are predominantly in the LL (61+4%) with few in the LR (26+4%) and UR 
(13+3%). Hypoxia in utero significantly shifted this distribution with a -18% loss in LL, -
3% in LR and subsequent gain of +21% in the UR. Together, this pattern of results 
indicates that hypoxia in utero increased the organization between a-Actin and SM-MHC, 
a marker for mature contractile smooth muscle cells. While SM-MHC is considered to be 
the main myosin heavy chain isoform expressed in mature, fully differentiated contractile 
smooth muscle, NM-MHC is generally expressed more abundantly in immature smooth 
muscle, especially in the fetus. A similar distribution at baseline was noted for NM-MHC 
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and a-Actin in normoxic arteries with the majority of pixels in LL (58+5) and few in LR 
(23+4), and UR (18+4). Hypoxia in utero significantly shifted this distribution with a -
12% loss in the LL and -17% loss in LR with subsequent increase of +29% increase in 
UR. Together, this pattern of results indicates that hypoxia in utero also increased the 
organization between a-Actin and NM-MHC.  
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Figure 1. Hypoxia in Utero Alters Endothelium-Dependent Effect of VEGF on 
Contractile Function.   
Middle cerebral arteries harvested from fetal sheep maintained at 3820 m for 110 days 
(Hypoxic) or at sea level (Normoxic) were denuded of endothelium or left intact prior to 
24hr organ culture with VEGF and undergoing functional contractility assays. A standard 
length-tension protocol was performed as described previously, for details see methods. 
Arteries were cut transversely into 2mm segments and used to determine stretch-induced 
myogenic stresses at different strains applied in increments of the unstressed diameter, 
from 1 to 3.3. Stiffness was determined as relation between passive stress and stretch, 
measured by Young’s modulus. Myogenic stress was calculated as the maximum 
spontaneous stress measured in PBS under resting conditions minus the passive stress in 
EGTA for each strain ratio. Active potassium-induced stress was calculated as maximum 
stress in 122 mM K+ isotonic Krebs buffer minus the spontaneous stress in PBS at each 
strain ratio. Organ culture with VEGF did not significantly alter artery structural 
characteristics such as thickness and stiffness for either normoxic or hypoxic arteries. 
Denudation of the endothelium increased stretch-dependent stress only in normoxic 
arteries; hypoxic acclimatization ablated the effect of endothelium removal. Hypoxia did 
not significantly alter potassium-induced stress but denudation of the endothelium 
decreased potassium-induced stress in both normoxic and hypoxic arteries. Error bars 
indicate SEM for arteries from 6 normoxic and 7 hypoxic fetuses with all denoted 
significant differences are at P<0.05. 
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Figure 2. Hypoxia in Utero Increases MHC Isoform Colocalization with AA.   
Middle cerebral arteries harvested from fetal sheep maintained from normoxic and hypoxic 
fetal sheep underwent confocal microscopy. Arteries were fixed immediately upon harvest 
in paraformaldehyde, paraffin-embedded, sectioned coronally at 5 µm and immunostained 
for myosin heavy chain isoforms NM-MHC or SM-MHC (red) and SM-αA (green). 
Colocalizations of SM-AA with MHC isoforms are displayed in the merged images 
(yellow). Summarized above are the pixel distributions for each of the 4 main experimental 
groups for two different marker pairs: SM-MHC with SM-αA in the upper panels, and NM-
MCH with SM-AA in the lower panels.  For each marker pair within each experimental 
group, the total of all pixels in the Low MHC / Low AActin (LL), Low MHC / High AActin 
(LR), and High MHC / High AActin (UR) categories is 100%.  Please note that the vertical 
scale is the same within each panel for ease of comparison.  For baseline normoxic arteries, 
the distribution of both SM-MHC and NM-MHC colocalization with AA is predominantly 
in LR with ~60% of pixels. Chronic hypoxia caused a rightward shift in pixel distribution 
toward the UR High MHC / High AActin category for both SM-MHC and NM-MHC 
colocalization with SM-αA.  Error bars indicate SEM for n values of 8 normoxic fetuses 
and 3 hypoxic fetuses.  Asterisks (*) denotes significant differences between normoxic and 
hypoxic values at P<0.05. 
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Figure 3. Hypoxia in utero alters endothelium-dependent effect of VEGF on MHC 
colocalization pattern with SM-αA.  
To elucidate the effect of hypoxia on the endothelial NO-PKG pathway, matched intact 
and denuded arteries from normoxic and hypoxic fetal sheep underwent organ culture with 
0, 10 ng/ml VEGF, the eNOS inhibitor LNAME (100uM), or with 10 ng/ml VEGF ± 
100uM LNAME. Representative images are displayed in Figure 3.  Hypoxia in utero 
altered endothelial-dependent effect of VEGF on Alpha Actin (RED 633nm) and myosin 
heavy chains (GREEN 488nm) organization. YELLOW represents pixels that are positive 
for both-Alpha Actin and MHC. Using this dual-label fluorescent confocal microscopy to 
quantify the extent of colocalization between-Alpha Actin and myosin. Shown above is a 
single image from each of the 4 different colocalization groups undergoing 4 treatments 
that represent a total of 365 images. For each treatment group, n values greater than 6 in 
all groups. 
 
 88 
Hypoxia in Utero Alters Endothelial Response to VEGF and Smooth Muscle 
Contractile Protein Organization 
To assess how hypoxia in utero alters endothelial response to VEGF and influence 
on the smooth muscle phenotype, perturbation of the NO-PKG pathway with and without 
stimulus by VEGF was performed in artery segments from normoxic and hypoxic 
animals. To separate out the endothelial component from direct action of VEGF on 
smooth muscle, one MCA from each animal was denuded of endothelium and the 
contralateral side left intact as described in the methods before being dissected into 
segments and cultured in the presence of 0 or 10 ng/ml VEGF, 100uM LNAME, or 
100uM LNAME + 10ng/mL VEGF for 24hrs as described. Segments designated for 
colocalization analysis underwent fixation, staining and imaging per the 
Immunohistochemistry and Confocal protocol.  Colocalization of the mature contractile 
SM-MHC isoform with SM-AA varied by quadrant. Given that these 3 quadrants total 
100 percent of the pixels physiologically relevant and that both SM-MHC isoforms and 
a-Actin have previously been established to distinguish different smooth muscle cell 
phenotypes, this analysis helps quantify possible shifts between different SMC phenotype 
subpopulations within the artery.  
 
Hypoxia Alters Endothelial Mediation of VEGF on MHC Colocalization with 
AA   
Figure 4A depicts SM-MHC and AA colocalization. Baseline treatment in organ 
culture of normoxic arteries with intact endothelium had a distribution pattern of myosin-
actin colocalization of 3 distinct populations in decreasing prevalence: LL with 49%, LR 
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with 12% and UR with 39%. This colocalization pattern was not significantly altered by 
chronic hypoxia or 24hr organ culture after denudation of the endothelium. Acute 24hr 
exposure to VEGF of endothelium-intact normoxic arteries increased LL at the expense 
of UR, with LL increased to +10, LR increased to +11% of control, and UR decreased -
21% of control. VEGF treatment of endothelium-denuded normoxic arteries enhanced 
this effect, with a greater increase in UR and loss of LL: LL increased to +15%, LR did 
not significantly change, UR decreased to -15%. Hypoxia decreased the influence VEGF 
treatment in endothelium-intact arteries, with similar shifts of population but none 
statistically significant at the p < 0.05.  Hypoxia inverts the influence of VEGF treatment 
on endothelium-denuded arteries in UR only:  LL did not significantly change with -4%, 
LR increased to +5%, UR did not significantly change with -1%. Intact arteries contain 2 
prominent cell populations, the endothelium and smooth muscle cells excluding a 
minimal population of pericytes and neurons that are present in the adventitial wall. By 
taking the difference of the effect of VEGF on endothelium intact arteries (predominantly 
Endothelium + Smooth muscle) minus the effect of VEGF on endothelium denuded 
arteries (predominantly Smooth muscle), we hoped to determine the component of the 
shift in colocalization populations due to hypoxic changes of the endothelium alone. The 
far right panel in Figures 5-8 for both A and B represents this Difference of the Difference 
or in formula form  = Intact  (VEGF – Ctrl)  -  Denuded (VEGF – Ctrl). Hypoxia changed 
endothelial contribution to VEGF influence on SM-MHC and Actin colocalization (See 
Figure 4A, right panels). VEGF action through the endothelium: decreased LL (-5%) in 
normoxic arteries while it increased LL (+8%) in hypoxic arteries, increased LR (+11%) 
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in normoxic arteries while it did not significantly change LR (-2%) in hypoxic arteries 
and decreased UR equally in both in normoxic (-6%) and in hypoxic (-6%) arteries.  
Figure 4B depicts NM-MHC and AA colocalization. Baseline treatment in organ 
culture of normoxic arteries with intact endothelium had a distribution pattern of myosin-
actin colocalization in control arteries demonstrates the 3 distinct populations in 
decreasing prevalence/abundance: LL with absolute 43%, LR with absolute 32%, UR 
with absolute 26%. This colocalization pattern was not significantly altered by chronic 
hypoxia or 24hr organ culture after denudation of the endothelium. Acute 24hr exposure 
to VEGF increased the LL quadrant in normoxic (equally in denuded and intact arteries) 
and in hypoxic arteries. VEGF treatment of endothelium-intact normoxic arteries 
increased LL at the expense of both other quadrants, LR decreased more than UR:  LL 
increased to +20%, LR decreased to -14%, UR insignificantly decreased to -7%. VEGF 
treatment of endothelium-denuded normoxic arteries had a similar increase in LL but at a 
greater expense of UR instead of LR: LL increased to +20%, LR decreased to -10%, UR 
decreased to -10%. As with SM-MHC, hypoxia significantly decreased the influence of 
VEGF treatment in endothelium-intact arteries, with similar shifts of population but with 
none statistically different from control at the p < 0.05. Hypoxia accents the influence of 
VEGF treatment on endothelium-denuded arteries in LR only, inverting the effect of the 
endothelium: LL insignificantly increased +11%, LR decreased to -15%, UR 
insignificantly increased +4%. Hypoxia changes endothelial contribution to VEGF 
influence on NM-MHC and Actin colocalization (See Figure 4B, right panels). VEGF 
action through the endothelium did not significantly alter LL in normoxic arteries (0%) 
while it decreased LL in hypoxic arteries (-4%). Decreased LR in normoxic arteries (-
 91 
3%) but increased LR in hypoxic arteries (+9%). Increased UR in normoxic arteries 
(+3%) while decreasing UR in hypoxic arteries (-5%). Thus VEGF is acting primarily 
through the smooth muscle in normoxic arteries and hypoxic arteries. However, hypoxia 
appears to sensitize the endothelium to VEGF which partially opposes the direct effect on 
the smooth muscle to decrease synthetic NM-MHC colocalization with AA. 
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Figure 4. Chronic Hypoxia Alters Endothelium-Dependent Effect of VEGF on MHC 
Colocalization Pattern with SM-αA.  
Endothelium intact and denuded arteries from normoxic and hypoxic animals were organ 
cultured in the presence or absence of 10ng/mL VEGF, underwent colocalization assays 
and quadrant analysis. The far left column is raw percentage of pixels by quadrant. The 
middle column is the differences due to treatment in 24hr organ culture, in this case VEGF. 
The far right column is differences of this difference or  due to the endothelium (Intact 
– Denuded). Among controls, the distribution pattern did not change with chronic hypoxia 
or denudation of the endothelium for both SM-MHC and NM-MHC. Figure 4A: Unlike 
hypoxia, acute exposure to VEGF shifted both SM-MHC and NM-MHC colocalization 
with SM-αA pixels from UR to LL in normoxic arteries and this is modestly amplified by 
the presence of the endothelium (Intact vs denuded). This effect is lost following hypoxic 
acclimatization of the endothelium and smooth muscle. As illustrated in Figure 4B, far 
right column, the normoxic endothelium contributes a shift in SM-MHC towards the LR 
while the hypoxic endothelium modestly shifts SM-MHC colocalization to the LL. Stated 
another way, the presence of the endothelium appears to amplify the effect of VEGF 
compared with endothelium-denuded in normoxic arteries but not in hypoxic arteries. For 
NM-MHC colocalization, VEGF causes a similar increase in LL that is diminished by the 
presence of the endothelium. The net shift induced by VEGF through the endothelium 
increases UR in normoxic and LR in hypoxic arteries. All differences are at P<0.05. 
Asterisks (*) denotes significant differences between endothelium intact and denuded 
values for either normoxic or hypoxic arteries. The † denotes significant differences 
between normoxic and hypoxic values. The star (*) denote significant difference in the 
effect of VEGF modification to the MHC and SM-αA colocalization pattern through the 
normoxic vs hypoxic endothelium. Error bars indicate SE for n ≥ 6 for all groups. 
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Hypoxia Does Not Alter Baseline Endothelial Mediation of MHC 
Colocalization with AA 
Figure 5A depicts SM-MHC and AA colocalization. Please see discussion of 
Figure 4 for comparison among baseline controls for Normoxic (intact and denuded) and 
Hypoxic (intact and denuded) treatment groups. Note bars in graph are ordered with 
perspective of the contribution by the endothelium, where baseline minus LNAME 
inhibition treatment. Acute 24hr inhibition of baseline eNOS with LNAME did not 
significantly alter any colocalization quadrant in endothelium intact arteries while slightly 
increasing both LL and LR, and decreasing UR in endothelium denuded arteries for both 
normoxic and hypoxic arteries. (Figure 5A, middle panels) LNAME treatment of 
endothelium-intact normoxic arteries does not significantly alter baseline unstimulated 
endothelial function on any quadrant. LNAME treatment of endothelium-denuded 
normoxic arteries enhanced the modest effect of endothelial intact arteries, with an 
increase in LL and LR at the expense of UR: LL decreased -7%, LR decreased -5% of 
control, UR increased +12%. Hypoxia did not alter the influence LNAME inhibition in 
endothelium-intact arteries, like with normoxic no significant shift among the quadrants 
occurred at unstimulated baseline. Hypoxia matches the influence of VEGF treatment on 
endothelium-denuded arteries with normoxic arteries, increasing LL at the expense of 
UR: LL decreased -9%, LR did not change, UR increased +9%. Hypoxia does not change 
baseline unstimulated endothelial contribution to LNAME influence on SM-MHC and 
Actin colocalization (See Figure 5A, right panels). LNAME inhibition through the 
endothelium decreased LL in normoxic (-6%) and in hypoxic arteries (-7%), decreased 
LR in normoxic (-2%) and hypoxic (-2%) arteries, increased UR in normoxic (+8%) and 
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hypoxic (9%). Hypoxia is not altering baseline endothelial or direct smooth muscle 
LNAME pathways upstream of SM-MHC and AA colocalization. 
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Figure 5. Chronic Hypoxia Alters Endothelium-Dependent Effect of L-NAME on 
MHC Colocalization Pattern with SM-αA.  
Endothelium intact and denuded arteries from normoxic and hypoxic animals were organ 
cultured in the presence or absence of 100uM LNAME, underwent colocalization assays 
and quadrant analysis as described in the text. The far left column is raw percentage of 
pixels by quadrant. The middle column is the differences due to treatment in 24hr organ 
culture, in this case the NOS inhibitor L-NAME. The far right column is differences of the 
treatment difference or  due to the endothelium (Intact – Denuded). Figure 5A: L-
NAME inhibition of basal NO increases LL for SM-MHC and SM-αA colocalization pixel 
distribution primarily in endothelium-denuded arteries (LEFT PANEL) and this is not 
significantly altered by hypoxic acclimatization (RIGHT PANEL). Figure 5B: L-NAME 
does alter NM-MHC and SM-αA colocalization pixel distribution (LEFT PANEL) with a 
shift toward UR through the normoxic endothelium that is amplified through hypoxic 
endothelium (RIGHT PANEL).  Asterisks (*) denotes significant differences between 
endothelium intact and denuded values for either normoxic or hypoxic arteries at P<0.05. 
The † denotes significant differences between normoxic and hypoxic values at P<0.05. The 
Star (*) denotes significant difference in the effect of VEGF modification to MHC and 
SM-αA colocalization pattern through the normoxic vs hypoxic endothelium. Error bars 
indicate SEM for n ≥ 8 for all groups. 
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Figure 5B depicts NM-MHC and AA colocalization. Please see discussion of 
Figure 4 for comparison among baseline controls for Normoxic (intact and denuded) and 
Hypoxic (intact and denuded) treatment groups. Acute 24 hr inhibition of baseline eNOS 
with LNAME marginally increased LR +5% in endothelium-intact arteries for both 
normoxic and hypoxic arteries while decreasing LL -12% and increasing UR +7% in 
normoxic denuded arteries and hypoxia enhanced this effect (Figure 5B, middle panels). 
Hypoxia modestly increased the influence LNAME inhibition in endothelium-intact 
arteries on NM-MHC and AA colocalization further decreasing LR and increasing UR at 
unstimulated baseline: LL did not significantly change -4%, LR increased +7%, UR did 
not significantly change -3%. Hypoxia accentuated the influence of LNAME treatment 
on endothelium-denuded arteries compared with normoxic arteries, increasing LL at the 
expense of UR and inverting the action through the endothelium on UR: LL decreased -
13%, LR did not change +2%, UR increased +11%. Hypoxia changes endothelial 
contribution to VEGF influence on NM-MHC and Actin colocalization (See Figure 5B, 
right panels). LNAME inhibition through the endothelium:  decreased LL in normoxic (-
7%) and hypoxic (-9%) arteries, did not change LR in normoxic (0%) arteries but 
significantly decreased in hypoxic (-6%) arteries, modestly increased UR in normoxic 
(+6%) arteries and majorly increased UR in hypoxic (+14%) arteries. Clearly the 
LNAME is acting directly on the smooth muscle or some other non-endothelial cell type 
in the artery wall. LNAME acting through non-endothelial LNAME targets is causing a 
shift toward decreased synthetic NM-MHC colocalization with AA while LNAME 
targets within the endothelium is acting to increase synthetic NM-MHC colocalization 
with AA.  
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Hypoxia Does Alter VEGF Stimulated Endothelial Mediation of MHC 
Colocalization with AA through NO-Dependent and NO-Independent Pathways 
Figure 6A depicts SM-MHC and AA colocalization. VEGF stimulation in organ 
culture of normoxic arteries with intact endothelium had a distribution pattern of LL with 
absolute 59%, LR with absolute 23%, UR with absolute 18%. This colocalization pattern 
changed with hypoxia: decreased in LL (endothelium-denuded) and increased in UR 
(endothelium-intact). This colocalization pattern also decreased with denudation of the 
endothelium in LR. Compared to acute 24hr exposure to VEGF alone, VEGF + LNAME 
decreased LL and increased UR in normoxic (more in denuded than intact arteries). This 
effect was present but minimized in hypoxic arteries. Figure 6A, middle panels. LNAME 
partial inhibition of VEGF stimulated normoxic arteries with intact endothelium resulted 
in a modest increase in UR with a prominent complimentary decrease of LR:  LL did not 
change -4%, LR decreased -7%, UR increased +11%. Partial inhibition of VEGF with 
LNAME in normoxic arteries without endothelium resulted in an even large increase of 
UR and decrease in LL: LL decreased -16%, LR decreased -7%, UR increased +23%. 
VEGF stimulation of hypoxic endothelium-intact arteries were less inhibited by LNAME 
than normoxic endothelium. VEGF stimulation of hypoxic endothelium-denuded arteries 
were less inhibited by LNAME than normoxic endothelium-denuded arteries. Hypoxia 
changes endothelial contribution to VEGF influence on SM-MHC and Actin 
colocalization (See Figure 6A, right panels). LNAME partial inhibition of VEGF action 
through the endothelium greatly decreased LL in normoxic (-13%) while minimally 
increased in hypoxic (+4%) arteries, with no change in LR in normoxic (+1%) while 
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slightly decreasing in hypoxic (-5%) arteries, greatly increased UR in normoxic (+12%) 
with no change in hypoxic (+1%) arteries. 
Figure 6B depicts NM-MHC and AA colocalization. VEGF stimulation in organ 
culture of normoxic arteries with intact endothelium has a distribution pattern: LL with 
absolute 62%, LR with absolute 18%, UR with absolute 19%. This colocalization pattern 
changed with hypoxia: decreased in LL with complimentary increase in UR (for 
endothelium-intact arteries). This colocalization pattern also decreased with denudation 
of the endothelium in UR for normoxic arteries and LR for hypoxic arteries. LL increased 
with denudation in hypoxic arteries. Compared to acute 24hr exposure to VEGF alone, 
VEGF + LNAME decreased LL and increased LR and UR in normoxic (more in denuded 
than intact). This trend was present but minimized in hypoxic arteries (again more in 
denuded than intact). Figure 6A, middle panels. LNAME partial inhibition of VEGF 
stimulated normoxic arteries with intact endothelium decreased in LL and increased LR: 
LL decreased -13%, LR increased +10%, UR did not change significantly -2%. Partial 
inhibition of VEGF with LNAME in normoxic arteries without endothelium resulted in 
an even large increase of LR and UR with decrease in LL: LL decreased -28%, LR 
increased +15%, UR increased +13%. VEGF stimulation of hypoxic endothelium-intact 
arteries were less inhibited by LNAME than normoxic endothelium: LL did not change -
3%, LR increased +9%, UR did not change -6%. VEGF stimulation of hypoxic 
endothelium-denuded arteries were equally inhibited by LNAME than normoxic 
endothelium-denuded arteries: LL decreased -25, LR increased +18%, UR did not change 
significantly +7%. Hypoxia accentuated endothelial contribution to VEGF influence on 
NM-MHC and Actin colocalization (See Figure 6B, right panels). LNAME partial 
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inhibition of VEGF action through the endothelium decreased LL in normoxic (-16%) 
while minimally increased in hypoxic (-22%) arteries; increased LR in normoxic (+5%) 
while slightly decreasing in hypoxic (+9%) arteries; increased UR in normoxic (+11%) 
with no change in hypoxic (+13%) arteries. VEGF action through intact endothelium is 
partially inhibited by LNAME equally in both normoxic and hypoxic arteries with respect 
to NM-MHC and AA colocalization. Hypoxic smooth muscle plays a greater role than 
the endothelium in LNAME action following VEGF stimulation.  
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Figure 6. Chronic Hypoxia alters endothelium-dependent effect of VEGF-induced 
NO on MHC colocalization pattern with SM-αA.  
Endothelium intact and denuded arteries from normoxic and hypoxic animals were organ 
cultured in 10 ng/ml VEGF ± 100uM LNAME, underwent colocalization assays and 
quadrant analysis as described in the text.  The far left column is raw percentage of pixels 
by quadrant. The middle column is the differences due to treatment in 24hr organ culture, 
in this case VEGF stimulation with and without the NOS inhibitor L-NAME. The far right 
column is differences of this difference or  due to the endothelium (Intact – Denuded). 
Figure 6A: L-NAME inhibition of VEGF-stimulated NO decreases SM-MHC and SM-αA 
colocalization pixel distribution from LL and increases UR. This response is greater in 
endothelium-denuded arteries and this is lost with hypoxic acclimatization. Figure 6B: L-
NAME inhibition of VEGF-induced NO decreases NM-MHC and AA colocalization pixel 
distribution with a shift toward UR from LL through the normoxic endothelium. This effect 
is amplified by hypoxic acclimatization of the endothelium. Asterisks (*) denotes 
significant differences between endothelium intact and denuded values for either normoxic 
or hypoxic arteries at P<0.05. The † denotes significant differences between normoxic and 
hypoxic values at P<0.05. The Star (*) denotes significant difference in the effect of VEGF 
modification to MHC and SM-αA colocalization pattern through the normoxic vs hypoxic 
endothelium. Error bars indicate SE for n ≥ 8 for all groups. 
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Discussion 
This study offers five original findings. First, hypoxia in utero significantly alters 
cerebrovascular contractile response following future VEGF exposure. Second, this 
response to subsequent exposure to VEGF is mediated through both the endothelium and 
smooth muscle. Third, hypoxia in utero alters contractile protein organization in the 
cerebrovascular smooth muscle, specifically among SM-MHC, NM-MHC and SM-AA 
with characteristic colocalization patterns. Fourth, these colocalization patterns serve to 
characterize multiple SMC phenotypes within the wall and thus enable quantification of 
shifts between subpopulations of SMC phenotypes from baseline. Fifth, hypoxia in utero 
alters the endothelial regulation of VSM contractile function and phenotype in part 
through changes to the NO pathway. Together, these findings support the hypothesis that 
hypoxia in utero alters endothelial influence on cerebrovascular smooth muscle 
contractile function and phenotype. 
 
Hypoxic Acclimatization Alters Artery Structure and Function  
Hypoxia induces vascular remodeling with changes in artery structure that 
manifests as increased artery thickness and changes in contractile force production, 
including ligand-, stretch-, and potassium-induced contraction (17). Hypoxic remodeling 
is tissue-specific with unique responses in various tissues such as pulmonary, large 
vessels such as the common carotid or the smaller muscular arteries such as the middle 
cerebral (24). This suggests that the mix of cell phenotypes present and their history of 
prior hypoxic exposure will control the response to any subsequent hypoxic stress. 
Hypoxia also alters more than artery structure; it alters contractile behavior. These 
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changes may be mediated in part through prolonged exposure to various factors, 
including contractants, vasodilators, and vasotrophic factors such as VEGF. This 
response can even change for a single factor solely due to the duration of the exposure. 
Likewise, the duration of hypoxic exposure from acute, intermittent, to long-term chronic 
hypoxia stimulate distinct or even opposing responses.  
It has also been shown that hypoxic vascular remodeling alters intercellular 
communication between the endothelium and smooth muscle. Chronic hypoxia has been 
shown to alter activation-coupling of intracellular pathways such as PKG and 
modification of downstream proteins within the contractile apparatus (13). These include 
changes in the repertoire of contractile protein types, abundance, and subcellular 
organization, which in turn represents a shift in SMC phenotype. (21, 23). These changes 
serve to influence any potential future vascular remodeling consequent to hypoxic 
challenge. 
Four VSM phenotypes have traditionally been described along a developmental 
spectrum from proliferative, migratory, synthetic, and the mature contractile type (7, 21, 
23). It appears that certain SMCs within a tissue retain the ability to de-differentiate along 
this spectrum to functionally adapt as needed to a changing environment (7).  Such 
response represents an adaptation that promotes short-term survival as a biological 
necessity.   Acutely, vascular smooth muscle is thought to act principally to maintain 
vascular tone through contractile force production. However, other VSM phenotypes are 
vital for the frequent remodeling of the cerebral vasculature, including synthesis of the 
ECM by non-contractile phenotypes. 
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Extended duration of exposure to otherwise normal physiologic stimulus can alter 
the long-term effects (13, 20, 21). Hypoxia alters the response to VEGF with transient 
upregulation of receptors (2). Like growth factors, chronic exposure to usually transient 
vasocontractants such as endothelin can promote a SMC phenotypic shift toward a 
synthetic VSM phenotype, with increased ECM production which enhances the structural 
and elastic properties of cerebral vessels and promotes their ability to maintain vascular 
tone (12). Acute vasodilators such as NO and downstream activation of PKG have been 
shown to induce the contractile SMC phenotype with chronic exposure (13, 20). 
Similarly, VEGF, a central growth factor in hypoxic vascular remodeling, has been 
shown to activate eNOS, which stimulates NO release with consequent activation of PKG 
(4). Together, these findings support the hypothesis that hypoxia alters smooth muscle 
phenotype and function; and that this occurs in part through changes in endothelial 
regulation. The extent to which these effects alter endothelial factor release and 
downstream pathways remain largely unreported.  
 
Hypoxic Acclimatization Altered Endothelial and Smooth Muscle Response to 
VEGF  
In the present study, hypoxia suppressed contractile function, and the endothelial 
component of this response to VEGF was ablated (Figure 1, Upper Panels) raising the 
possibility that hypoxia altered either VEGF receptors, or altered downstream endothelial 
influence on SMC contractile signaling. Hypoxia did not alter K+-induced stress; but 
VEGF in the presence of the endothelium did increase K+-induced stress regardless of 
normoxic/hypoxic status (Figure 1, Lower Panels). Previous work from many 
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laboratories, including our own (5), (10) have established that changes in vascular 
structure and function are frequently coupled with changes in vascular smooth muscle 
phenotype (15). To explore the possibility that hypoxia-induced changes in MCA 
function may have involved shifts in smooth muscle phenotype, the present study 
employed quantitative confocal microscopy to examine MCAs from the same treatment 
groups used for contractility measurements (Figure 2).  These measurements quantified 
changes in the colocalization of smooth muscle α-actin with the smooth-muscle (SM-
MHC) and non-muscle (NM-MHC) isoforms of myosin heavy chain (MHC) to identify 
transitions in phenotype, as previously reported (10, 15). A novel strength of the non-
parametric colocalization analysis employed in these studies was that all colocalized 
pixels fell into one of three main phenotypic categories depending on the relative 
intensities of the markers examined.  This assignment emphasized shifts between the 
phenotypic categories in response to hypoxia and VEGF.  
As indicated by changes in colocalization between SM-AA and the MHC 
isoforms, hypoxia in utero appears to promote differentiation to a contractile phenotype 
(Figure 2) as indicated by an increase in colocalized pixels with high intensities for SM-
MHC.  Unexpectedly, hypoxia also strongly increased the fraction of colocalized pixels 
with high intensities for NM-MHC denoting an increase in the partially de-differentiated 
synthetic phenotype. The rightward shift in pixel distribution implies an increase in the 
proportion of cells in a contractile phenotype. This suggests an upregulation of 2 distinct 
populations of SMC with different phenotypes; the contractile, and the partially de-
differentiated synthetic.  
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Hypoxic Acclimatization Altered Endothelial Mediation of VEGF on SMC 
Phenotype Distribution 
As indicated by changes in colocalization between SM-AA and the MHC 
isoforms, VEGF appeared to promote synthetic differentiation in normoxic but not 
hypoxic arteries (Figure 4).  While hypoxia seemed to increase colocalization for both 
MHC isoforms, acute secondary exposure to VEGF in organ culture resulted in decreased 
pixel intensity for SM-MHC colocalization. VEGF also correspondingly increased the 
fraction of colocalized pixels with low intensities for both SM-AA and SM-MHC. This 
leftward shift in pixel distribution was consistent with a decrease in the proportion of 
smooth muscle cells in a contractile phenotype (Figure 4, Upper Panels). The concept of 
isolating the purely endothelial component by observing the differences between intact 
and denuded arteries was introduced by John Magnus.  VEGF action through the 
endothelium resulted in a loss of pixels in both UR and LL with a subsequent increase in 
LR for SM-MHC colocalization with SM-AA suggesting an increase in SM-AA but 
unchanged re-organization with SM-MHC. Hypoxia decreased intensity for both intensity 
and colocalization for both markers with an increase in LL. VEGF in organ culture also 
significantly decreased the fraction of colocalized pixels with high intensities for both 
NM-MHC and SM-AA, and correspondingly increased the fraction with low intensities 
for both markers; this leftward shift in pixel distribution implies a decrease in the 
proportion of cells in a non-contractile phenotype (Figure 4, Lower Panels).  The 
influence of VEGF through the endothelium significantly changed with hypoxia, increase 
LL colocalization for SM-MHC and increasing LR for NM-MHC. 
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Hypoxic Acclimatization Did Not Alter Baseline Action of Endothelial NO on 
SMC Phenotype 
As indicated by changes in colocalization between SM-AA and the MHC 
isoforms, basal NO did not appear to promote de-differentiation of SMCs in normoxic or 
hypoxic arteries (Figure 5A). L-NAME inhibition of basal NO modestly increased LL 
for SM-MHC and SM-αA colocalization pixel distribution primarily in endothelium-
denuded arteries (LEFT PANEL) and this is not significantly altered by hypoxic 
acclimatization (RIGHT PANEL). Interestingly L-NAME inhibition of basal NO did 
increase NM-MHC and SM-αA colocalization pixel distribution with a shift toward UR 
through the normoxic endothelium that is amplified through hypoxic endothelium 
(Figure 5B). This suggests that NM-MHC organization may be more sensitive to NO 
regulation. The influence of the endothelium significantly changed with hypoxia only 
with increasing organization of the synthetic-denoting NM-MHC. 
 
Hypoxic Acclimatization Did Alter VEGF-Stimulated Endothelial NO 
Mediation of SMC Phenotype 
Unlike basal NO, VEGF stimulated NO through normoxic endothelium 
significantly increased the contractile SM-MHC colocalization with SM-AA. This effect 
of VEGF through the endothelium was lost with hypoxic acclimatization of the 
endothelium however, the hypoxic endothelium retained its effect on NM-MHC 
colocalization with SM-AA, re-iterating its independent regulation from SM-MHC. 
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Overview 
As a whole, the results of this study emphasize that hypoxia can alter the 
structure, contractile protein organization, contractility and smooth muscle phenotype of 
cerebral arteries through changes in endothelial regulation of NO-dependent and NO-
independent pathways. Given that many but not all of these effects were stimulated by 
VEGF and then partially attenuated by inhibition of eNOS with L-NAME, these findings 
reinforce the hypothesis that hypoxia alters endothelial response and downstream 
influence on smooth muscle through NO-dependent and NO-independent pathways. 
Consistent with this idea are multiple findings that hypoxia upregulates VEGF, that 
VEGF leads to release of NO, and that NO alters SMC function. 
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Figure 7. Chronic hypoxia alters endothelial and smooth muscle response to 
secondary VEGF through altered NO-dependent and NO-independent pathways.  
Hypoxia in Utero Alters Endothelial influence on Smooth Muscle Phenotype and Function. 
Hypoxia can influence smooth muscle function and phenotype through changes in 
endothelial influence via NO-dependent and NO-independent pathways. Secondary 
activation of the vessel with VEGF seems to stimulate pathways in the endothelium that 
have changed with hypoxic acclimatization. NO inhibition with LNAME appears to 
perturbate some but not all of this effect suggesting there are both NO-dependent and NO-
independent components. Likewise, VEGF direct stimulation of smooth muscle in denuded 
arteries and combined direct + indirect stimulation in endothelium-intact arteries appears 
to alter downstream organization of MHC with SM-AA. This occurs with shifts between 
smooth muscle phenotype within the medial wall as demonstrated by novel quadrant 
characterization and these shifts are strongly associated with changes in contractility.  
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Introduction 
Vascular remodeling is a dynamic process to optimize delivery of oxygen and 
nutrients to meet the metabolic demands of the tissue. It can be directed by transient or 
chronic, as well as local versus systemic exposures to hypoxia that may contribute to 
numerous pathophysiologic processes (16, 48) including ischemia (29), hypertension 
(46), and atherosclerosis (37). This process not only alters the pathway and diameter of 
the vasculature but can also alter the inherent ability to maintain vascular tone, to recover 
from injury, and the response to future insults. Much of this remodeling takes place in the 
arterial smooth muscle cells (12, 40) with corresponding changes in contractility and 
vascular reactivity (24, 26, 27). These changes are thought to be coupled with 
conversions of smooth muscle phenotype that can be identified with characteristic 
changes in contractile proteins (24, 36) including smooth muscle-alpha actin (SM-AA) 
(31, 32) and various components of smooth muscle myosin including the myosin heavy 
chain (MHC) isoforms (36, 37). These have been shown to reliably and dynamically 
reveal corresponding changes in smooth muscle phenotype during both physiological 
(24), and pathophysiological (16, 40, 46) vascular remodeling. 
Several factors that drive vascular remodeling as well as phenotypic transitions of 
smooth muscle have been identified but remain incompletely understood. These include 
platelet-derived growth factor (15), fibroblast growth factor (35), transforming growth 
factor-β (3), and vascular endothelial growth factor (20, 31). These growth factors 
activate several intracellular pathways with possible release of intercellular factors for 
paracrine communication acting primarily at the serosal surface of the blood vessel, or 
between the endothelium and smooth muscle. In the latter category are endothelin and 
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NO (5, 9) that emanate from the vascular endothelium and act more prominently at the 
luminal surface. VEGF has been shown to alter activity of both. Other factors are 
released into both the interstitium and systemically into the bloodstream, thereby 
coordinating distributed effects on vascular structure and function. A prominent example 
in this latter category is Vascular Endothelial Growth Factor (VEGF) which has been 
recognized as a key mediator of angiogenesis (10).  VEGF has been shown to have 
trophic effects on numerous non-endothelial cell types including pericytes (42), CNS 
neurons (25), sympathetic neurons (28), skeletal muscle (4) and smooth muscle (6, 18, 
30). Equally relevant, the synthesis and release of VEGF are prominantly stimulated by 
hypoxia via several pathways (14, 43). Together, these characteristics give VEGF the 
potential to broadly influence vascular remodeling and phenotypic transformation of 
smooth muscle, particularly in response to chronic hypoxia and hypoxic acclimatization. 
The present study further explores the hypothesis that age-dependent hypoxic 
remodeling of artery structure and function occurs in part through VEGF with induced 
changes in smooth muscle phenotype that alters the response to subsequent exposure to 
VEGF in the future. Both the new baseline smooth muscle phenotype from hypoxic 
acclimatization and following secondary exposure to VEGF can be quantified by changes 
in contractile protein abundance and organization. Additionally, the trophic factors can 
act differentially from the adventitial face or from the luminal face and our development 
of transmural morphometry helps illustrate this. In the context of this study, artery 
“structure” was determined through measurements of medial layer thickness, unstressed 
diameter, and the transmural distribution and intracellular organization of smooth muscle 
contractile proteins.  In turn, intracellular organization and smooth muscle phenotype 
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were defined by the patterns of colocalization of Non-Muscle and Smooth Muscle 
Myosin Heavy Chain with Smooth Muscle-Alpha Actin (36, 37).  
 The experimental design focused on the hypoxic acclimatization and the altered 
effects of VEGF in vitro on artery structure, contractile protein organization, and function 
using established methods for immunoblotting, confocal microscopy, and measurements 
of in vitro contractility (6, 8). These experiments employed a low physiological 
concentration of VEGF at 3 ng/ml (13, 44) to minimize non-specific activation of non-
VEGF receptors (2). Experiments were performed in large conduit arteries to minimize 
influences attributable to the release of parenchymal metabolites. Comparisons between 
arteries harvested from sheep maintained at sea level, and those maintained at high 
altitude (3820 m) for 110 days served to define the effects of chronic hypoxia, as 
previously described (34) while the effects in organ culture were defined as the effects of 
VEGF. Vascular remodeling differs great in mature and immature arteries (7), therefore 
this paper includes comparisons between arteries from non-pregnant adult sheep and full 
term fetal lambs. Together, these approaches enabled a unique perspective of the altered 
response to VEGF in age-dependent hypoxic vascular remodeling and acclimatization.  
 
Materials and Methods 
All procedures used in these studies were approved by the Animal Research 
Committee of Loma Linda University, adhered to the policies and practices set forth by 
the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and 
have been previously described in detail (6, 47). 
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Tissue Harvest and Preparation 
Segments from common carotid arteries were collected under sterile technique for 
each protocol from fetal (139-142 days gestation) and young non-pregnant adult sheep 
(18-24 mo old) that had been maintained in normoxic (sea level) or hypoxic (3280 m) 
settings for the last 110 days of gestation. Tissue harvest was carried out on anesthetized 
pregnant ewes with 30mg/kg pentobarbital, followed by intubation, and then maintained 
under 1.5%-2.0% halothane. A midline vertical laparotomy enabled exteriorization of the 
anesthetized fetus followed by sacrifice via rapid removal of the heart and 
exsanguinations. Intravenous administration of 100 mg/kg pentobarbital was used to 
sacrifice the adult animals. Arteries were harvested and placed in sterile HEPES buffer 
solution (mM unless otherwise noted, 122.1 NACl, 25 HEPES, 5.15 KCl, 2.4 MgSO4, 50 
μM EDTA, 11.1 dextrose, 1.6 CaCl2). Arteries then underwent gentle surgical removal of 
all loose adipose and extracellular connective tissue followed by rod denudation of the 
endothelium as previously described (47). For each animal, the denuded carotid was then 
cut into 2-mm (for contractility and immunohistochemistry assays) and 3 mm lengths (for 
immunofluorescence assays), then distributed to the various protocols in matched 
treatment sets. 
 
Organ Culture 
As described previously (6) , each artery segment allocated for organ culture was 
maintained in untreated 12-well plates with DMEM (Sigma Aldrich, St. Louis, 
#M56469C) supplemented with: Na2HCO3 (3.7 g/L), 0.5% amino acid solution (Sigma 
Aldrich, St. Louis, #M5550), 1% non-essential amino acid solution (Sigma Aldrich, St. 
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Louis, #M7145), 4 mM glutamine (Sigma Aldrich, St. Louis, #G7513), 2% antibiotic-
antimycotic solution (Gibco, Carlsbad, #15240-096), and Gentamycin at 70 µg/ml 
(Gibco, Carlsbad, #15750-060). Cultures occurred in a humidified incubator with a 5% 
CO2¬ in room air at 37 ºC. 
Matched serial arteries were cultured in supplemented DMEM without FBS for 
the initial 24 hours and for an additional 24 hours in media containing DMEM (Control), 
with 3ng/mL VEGF-A165 (VEGF), or with 3ng/mL VEGF-A165 plus the VEGF-R 
inhibitor Vatalanib at 240nM (VEGF+Vat). This low physiological level of VEGF was 
selected in accordance with VEGF levels measured in sheep (44)  and to minimize 
binding of VEGF to non-VEGF receptor such as PDGF- as recently shown (2). 
Following organ culture, arteries were then submitted for fluorescent 
immunohistochemistry, Western blots, or contractility studies. For all cultured 
treatments, matched artery segments harvested fresh and uncultured were studied in 
parallel. 
 
Contractility Studies 
Artery segments allocated for contractility assay were mounted on wires in vitro 
between a micrometer slide and an isometric force transducer used to measure artery 
diameters. First, for 30 min mounted segments were equilibrated in calcium-replete Na+-
Krebs buffer containing (in mM) 122 NaCl, 25.6 NaHCO3, 5.17 KCl, 2.49 MgSO4, 1.60 
CaCl2, 2.56 dextrose, 0.027 EGTA, and 0.114 ascorbic acid. At 38 
oC, normal ovine core 
temperature, a buffer pH of ≈7.4 was maintained with continuous bubbling of 95% O2—
5% CO2. After initial equilibration, unstressed artery diameter (D0) was measured in each 
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segment at a passive tension of 0.03 g. Based on its D0 at strain values of D/D0 = 1.5, 1.8, 
2.1, 2.3, 2.7, 3.0, and 3.3, each artery’s working diameters (D) were calculated. 
Contractile stresses in mN/cm2 were measured in increasing order at each of these strain 
values, first under resting conditions to identify spontaneous myogenic tone, and then 
with contraction in a high potassium buffer including (in mM) 5.16 NaCl, 122.1 KCl, 
2.15 NaHCO3, 2.5 MgSO4, 0.027 EDTA, 11.08 Dextrose, 0.114 Ascorbic Acid, and 1.6 
ml CaCl2. Once the K
+-induced contraction stabilized, the arteries were replaced in the 
Na+-Krebs buffer, permitted to relax, then elongated to and equilibrated at the next 
highest stretch ratio. Once the max  K+-induced contraction had been achieved and 
identified, the arteries were then frozen in liquid nitrogen to rupture the cells. Next, the 
arteries were incubated in a calcium free Na+ Krebs buffer including 3mM EGTA; this 
was done to further inhibit SMC derived-force via Ca+2 sequestration. The degree of 
passive stress produced for each strain ratio applied was subsequently recorded for each 
descending stretch ratio. 
Active stress caused by high K+ was determined to be the difference between the 
magnitudes of the active stress measured immediately before and after applying the high 
K+ buffer. Active stress caused by spontaneous myogenic tone was determined to be the 
difference between the pre-treatment measure of plateaued spontaneous active tone and 
the post-treatment measure of passive stress after treatment with liquid N2 and EGTA 
treatment for each level of strain. Arterial stiffness was determined using the relations 
between strain and passive stress; the coefficient of stiffness was determined by with a 
monotonic exponential model using curve-fitting. 
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Fluorescent Immunohistochemistry 
Each artery segment was fixed in 4% neutral buffered EM-grade formaldehyde 
(Electron Microscopy Sciences, Hatfield, #15713S) overnight. Each segment was 
dehydrated and then embedded in paraffin, sectioned at 5 m, and plated. Each slide was 
deparaffinized in Histo-Clear (National Diagnostic, Atlanta, #HS-200), rehydrated in 
alcohol of decreasing grades, and then microwaved in a citrate buffer (pH 6.03) to expose 
antigenic sites. Permeabilization and blocking was done with 1% Bovine Serum Albumin 
(Santa Cruz Biotechnology, Santa Cruz, #SC-2323) and 0.1% Triton X-100 (Sigma 
Aldrich, St. Louis, #T-8787). Primary antibodies were stained with overnight and 
included: Monoclonal anti- α actin smooth muscle (Sigma Aldrich, St. Louis, A5228) @ 
1:200 with either polyclonal rabbit anti-human Non-Muscle Myosin Heavy Chain (NM-
MHC; CoVance, Princeton, PPR-445P) at 1:500 or polyclonal rabbit anti-bovine Smooth 
Muscle Myosin Heavy Chain (SM-MHC; Abcam, Cambridge, ab53219) at 1:500. The 
following day slides were washed for two 10 minute cycles in PBS and stained using the 
appropriate secondary antibody with DyLight 488 Conjugated (Pierce Chemical, 
Rockford, #35502) for two hours at room temperature. The secondary antibody was a 
goat anti-rabbit-488 (Thermo Scientific, Rockford, #35552 Lot LI150311). To minimize 
deterioration of the fluorescent dye, slides were then after kept in the dark. Following two 
10-minute cycles in PBS while covered, each tissue slide was mounted with a coverslip 
as well as SlowFade Gold anti-fade reagent with DAPI (Invitrogen, Carlsbad, S36939) 
then stored until imaged. Each image was captured using the Zeiss Imager A1. AX10 
Fluorescence microscope and the Spot software (Diagnostic Instruments, Inc. Ver 
4.6.4.5). 
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Transmural Morphometry 
Transmural morphometry was performed as previously described (6). In brief, 
along radial lines that extended from the basal lamina to the adventitial-medial junction, 
six scans of separate intensity were recorded using Image Pro Plus (MediaCybernetics, 
Version 6.0). Mapping fluorescent intensity relative to distance from the lumen, the radial 
scan lines were equally distributed at regular intervals of 60-degrees around the lumen. A 
value of “0” was assigned to the region immediately inside the basal lamina, and a value 
of “100” was assigned to the region just inside the adventitial-medial junction; this scale 
was used to normalize distance measurements relative to medial thickness. 
Calibration curves were calculated previously to compensate for the non-linear 
relation between fluorescent intensity and fluorophore, enabling conversion of 
fluorescent intensities in to relative concentrations. Using percentages of the normalized 
distance from the lumen, values of 5-15% were averaged and termed the “Lumen”, 
values of 45-55% were averaged and termed “Media”, and values of 85-95% were 
averaged and termed “Adventitial.” 
 
Confocal Microscopy 
Matched artery segments were collected, prepared and cut into 5 μm sections, 
deparaffinized, sectioned, and immunostained as described for Transmural Morphometry, 
with the exception that all sections were stained with primary monoclonal mouse anti-
sheep antibodies against SM-AA (Sigma-Aldrich, A5228, 1:200) and a second primary 
antibody against one of the MHC isoforms. Because in arterial smooth muscle the  
isoform of actin is the main isoform involved in smooth muscle contraction (32), all 
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colocalization of MHC was quantified relative to the abundance of  actin.  Because 
only alpha-actin is involved in smooth muscle contraction, changes in the other actin 
isoforms that can also be expressed in smooth muscle (45) should have little if any 
influence on smooth muscle contractility. The antibodies used to detect the MHC 
isoforms were as described in the Fluorescent Immunohistochemistry section. Following 
incubation with the primary antibodies, sections were washed in PBS, equilibrated in 
darkness for 2 h at room temperature with two secondary antibodies labeled with 
Dylight-488 to detect SM-AA and Dylight-649 to detect MHC, as indicated for 
Fluorescent Immunohistochemistry. Following secondary staining, sections were cover-
slipped using Slowfade Gold Antifade Reagent (S36936, Invitrogen), and then examined 
with an Olympus FV1000 confocal microscope at an optical section thickness of 0.7 μm, 
a lateral resolution of 200 nm, and a numerical aperture of 18. 
Antigen colocalization in confocal images was analyzed using FlouView software 
(version 2.1c), which provided multiple indices of co-localization including the Manders 
Colocalization Index 1 (actin signal in the denominator) that quantifies the portion of 
pixels that fluoresce for both MHC and SM-AA relative to the total number of pixels 
positive for SM-AA. Positive pixels were defined as having a fluorescent intensity equal 
to or greater than 5% of the maximum fluorescence intensity in the section. To eliminate 
cells with a small but significant above-threshold abundance of SM-AA characteristic of 
incompletely differentiated smooth muscle cells and some non-smooth muscle cell types 
(39), a second index of colocalization was developed. This second index, which we 
termed %Upper Right (%UR), was calculated to select for differentiated contractile 
smooth muscle as identified by high SM-AA abundance levels. This index counted only 
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pixels that fluoresced at or above the mean intensity threshold for SM-AA, which in 
essence was equivalent to recalculating the Colocalization Index 1 with an SM-AA 
threshold of 50% of maximum intensity. This method of analysis was derived from a 
flow-cytometry quadrant analysis, and thus was referred to as the percentage in the upper 
right quadrant of the scatterplot of SM-AA intensities against MHC intensities. From a 
general perspective, Colocalization Index 1 and %UR were both proportional to the 
fraction of actin-positive pixels that were also positive for MHC. Interestingly, the results 
obtained for both Colocalization Index 1 and %UR varied somewhat in absolute values, 
but were qualitatively similar.  
 
Westerns 
Each artery segment was homogenized via glass on glass in 8 M Urea, 500 mM 
NaCl, 20 mM Tris, 23 mM Glycine, 10 mM EGTA, and 10% Glycerol at pH 8.6, and 
also with the addition of a protease inhibitor cocktail at 5 µl per ml of buffer (Sigma-
Aldrich, Saint Louis, #M1745). Centrifugation for 20 minutes of the homogenate at 5,000 
G allowed for the supernatant to be collected, that was then separated by SDS-PAGE 
alongside a pooled reference. The pooled reference was harvested from adult ovine 
common carotid arteries and was used to calibrate sample abundances. Separated proteins 
were then transferred to nitrocellulose in Towbin’s buffer at 350mA for 90 minutes (25 
mM Tris, 192 mM Glycine, 10 and 20% Methanol) and blocked for 1 hour at room 
temperature with 5% milk in Tris-buffered saline at pH 7.5 (M-TBS) and using 
continuous shaking. Each subsequent wash and incubation was done in M-TBS with 
0.1% Tween-20. Incubation was done with the same primary antibodies as 
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immunohistochemistry, for 3 hours with anti-SM-AA 1:3000, anti-NM-MHC 1:1000 and 
anti-SM-MHC 1:20,000 for 3 hours. To achieve visualization, membranes were then 
incubated with a secondary antibody conjugated to DyLight 800 for 90 minutes (Pierce 
Chemical, Rockford, #46422) and imaged using LI-COR Bioscience’s Odyssey system.   
 
Data Analysis and Statistics 
Contractile stress was calculated as a ratio of force per cross-sectional area, where 
force was contractile tension (grams x acceleration due to gravity) and cross-sectional 
area (wall thickness x segment length) had been adjusted for changes with stretch as 
detailed previously (23, 33).  For immunofluorescence, intensity values within each 
segment were normalized to yield an area below the intensity-distance curve of unity, and 
calibrated against marker abundances measured with Westerns. For each marker, Western 
measurements were calibrated against a standard curve that was pooled from adult 
common carotids. For confocal, the median intensity for smooth-muscle α-actin was 
determined on a log scale, with pixels above the median denoted as “α-actin positive.” 
The percentage of SM-α Actin positive pixels co-localized with SM-MHC, or NM-MHC 
respectively was determined using confocal software and shown in figures below. All 
statistical comparisons were done using Behrin’s Fischer at the P>0.05 level with each 
animal contributing equally to each treatment group. 
 
Results 
Fetal and adult sheep from either normoxic or hypoxic settings were included in 
this study (Fetal- 7 normoxic and 7 hypoxic; Adult- 11 normoxic and 8 hypoxic). From 
each animal, endothelium denuded carotid arteries were harvested and adjacent artery 
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segments allocated to each treatment as a paired set totaling 436 artery segments (Fetal- 
112 normoxic and 96 hypoxic; Adult- 120 normoxic and 108 hypoxic). The term “n” 
denotes number of animals used in each experiment, not the number of segments. 
Statistical significance was defined at P < 0.05 for all assays unless noted otherwise, with 
all values in the form of means ± SEM. 
 
Chronic Hypoxia Neutralizes or Reverses the Effect of VEGF on Artery 
Function (Figure 1)  
All changes are difference with VEGF organ culture in % Ctrl. The second insult 
with VEGF further accentuated the increase in potassium induced contraction seen with 
hypoxia in adult (N -45.23.0 vs H +35.96.1) and showed desensitization to VEGF in 
fetal (N -15.64.3 vs H +8.910.0) arteries. As seen previously with myogenic tone, a 
distinct optimum stretch ratio occurred in fetal arteries at D/D0 2.1 while a broader range 
is seen in the adult between D/D0 2.1 and 2.7. This suggests age-dependent organization 
of contractile elements including extracellular organization of ECM, SMC size, and SMC 
heterogeneity as well as intracellular organization of desmosomes, SM-MHC and SM-
SM-αA.  Hypoxia followed by organ culture with VEGF also lessened the loss of stretch-
induced contraction in the adult (N -50.6  2.8% vs H -36.9 5.1%). Hypoxia + VEGF 
showed a small but significant increase in medial thickness in the fetus (N 2.0  1.57% vs 
H 8.4 4.4%) and a decrease in the adult (N 6.9  1.1% vs H -5.0 1%). The reverse in 
medial thinning in the adult coupled with increased contractile force suggests a possible 
shift toward a more efficient contractile SMC. 
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Chronic Hypoxia alters VEGF Action on Myosin Heavy Chain Expression and 
Distribution Across the Artery (Figure 2)  
Interestingly, similar trends of MHC distribution between medial layers were 
maintained under hypoxia and with/without VEGF, except for SM-MHC in the fetus. 
However hypoxia+VEGF shifted MHC expression towards the extreme marker ends in 
the fetus with NM-MHC (N 24.3  0.2% vs H 97.9 1.2%, Lumen) and SM-MHC (N -
29.4 0.1%, medial vs H 81.2 1.0%, luminal). In contract, adult arteries showed 
hypoxia followed VEGF showed sensitized the down regulation of SM-MHC (N -6.9  
0.1% vs H -21.0 0.3%, luminal), with NM-MHC losing reactivity to VEGF (N 39.3 
0.4% vs H 17.8 0.3%).  
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Figure 1. Chronic Hypoxia neutralizes or reverses the effect of VEGF on Artery 
Function.  
Endothelium-denuded common carotid arteries from fetal and adult sheep maintained at 
normoxic settings (N, sea level) or hypoxic settings (H, 3280 m for 110days) were placed 
in 48hrs Organ Culture (OC) with or without 3ng/mL VEGF. Both stretch induced 
(myogenic) and potassium-induced (active) contraction were determined at increasing 
multiples of the unstressed diameter (D0).  Organ culture with VEGF enhanced K+-induced 
contractions in the fetal and depressed it in adult arteries. Hypoxia ablated this response in 
the fetus and reversed the effect in the adult arteries. Error bars indicate SEM for arteries 
from a total of 31 animals: 7 Normoxic Fetal, 5 Hypoxic Fetal, 11 Normoxic Adult, and 8 
Hypoxic Adult. All differences denoated * are at P < 0.05. 
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Figure 2. Chronic Hypoxia alters VEGF action on Myosin Heavy Chain Expression 
and Distribution across the artery.   
Coronal sections of endothelium denuded carotid arteries from fetal and adult sheep 
(hypoxic and normoxic) were treated in 48hrs OC with or without 3ng/mL VEGF and 
immunostained for SM-MHC or NM-MHC (green signal). Cell nuclei were stained with 
DAPI (blue signal). Shown here are representative matched sections from a single animal 
for each experimental group.  Artery layers of smooth muscle were defined as Lumen (area 
just inside basal elastic elamina), Media (area midway between basal elastic lamina and 
adventitial-medial border), Adventitia (area immediately adjacent to the adventitial-media 
border). Analysis described in detail previously.  Each * denotes a difference at the P < 
0.05 level using the Behren’s Fischer test. Error bars indicate the combined SEM from both 
techniques: Immunofluorescence (6 normoxic fetal, 6 hypoxic fetal, 6 normoxic adult and 
5 hypoxic adult). Immunohistochemistry included n=7 for each of the four groups. 
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Chronic Hypoxia alters VEGF Action on Myosin Heavy Chain Expression and 
SM-AA Colocalization (Figure 3 and 4)  
All changes are difference with VEGF organ culture in % Ctrl. The second insult 
with VEGF diminished colocalization of NM-MHC in fetal normoxic but not hypoxic 
arteries. Similarly VEGF also decreased colocalization of mature contractile SM-MHC in 
fetal hypoxic but not normoxic arteries. In adults, colocalization of all MHC with SM-
AA decreased with VEGF in normoxic arteries and this same response was amplified in 
hypoxic arteries.   
 
Chronic Hypoxia Alters Receptor that VEGF Acts on to Alter K+- Induced 
Contractile Function (Figure 5)  
Vatalanib is a selective inhibitor for both primary VEGF receptors KDR and Flt-
1. Vatlanib inhibition of VEGF in OC had no effect in fetal arteries suggesting that 
VEGF may be acting through a non-VEGF receptor that is upregulated in the fetus. 
Inhibition of VEGF in adult arteries during OC was able to neutralize the decrease of 
potassium induced contraction and prevented the VEGF contractile enhancement. 
Vatalanib did not alter the optimum stretch ratio occurred in fetal arteries or in adult 
arteries.  
 
Chronic Hypoxia Alters Receptor that VEGF Acts on to Alter Stretch-Induced 
Contractile Function (Figure 6)  
Vatalanib was unable to inhibit contractile effects of OC with VEGF in fetal 
arteries. However in adult arteries, Vatalanib did successfully inhibit part of the effect of 
VEGF and this effect was not significantly altered by hypoxia.   
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Figure 3. Chronic Hypoxia Alters VEGF Action on Myosin Heavy Chain Expression 
and SM-AA Colocalization. 
Coronal sections of endothelium denuded carotid arteries from fetal and adult sheep 
(hypoxic and normoxic) were treated in 48hrs OC with or without 3ng/mL VEGF, fixed in 
4% paraformaldehyde, paraffin embedded, sectioned at 5 m, and immunostained for SM-
MHC (red signal) and SM-AA (green signal). Co-localization of the two are displayed 
below in merged images (yellow signal) and are representative matched sections from a 
single animal for each experimental group. 
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Figure 4. Chronic Hypoxia Alters VEGF-Induced SMC Phenotype.   
Coronal sections of endothelium denuded carotid arteries from 6 normoxic and 6 hypoxic 
fetal lambs and 6 normoxic and 6 hypoxic adult sheep were treated 48hrs in OC with or 
without 3ng/mL VEGF, then fixed and stained for immunostained for SM-MHC or NM-
MHC (red signal) and SM-AA (green signal) colocalization. Hypoxia+VEGF reverse 
effect of hypoxia or VEGF individually. Overall contractile MHC decreased (decreasing 
NM-MHC in normoxic and SM-MHC in hypoxic arteries) in fetal arteries. All denoted 
differences are at the P < 0.05 level.   
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Figure 5. Hypoxia Alters the Receptor that VEGF Alters K+-Induced Stress.   
Endothelium-denuded common carotid arteries from fetal and adult sheep maintained at 
normoxic settings (N, sea level) or hypoxic settings (H, 3280 m for 110days) were placed 
in 48hrs Organ Culture (OC) with 0ng/mL VEGF (Control), 3ng/mL VEGF (VEGF), or 
3ng/mL VEGF + 240nM Vatalanib (VEGF+Vatalanib) then underwent contractility assay. 
Potassium-induced (active) contraction was determined at increasing multiples of the 
unstressed diameter (D0).  Hypoxia diminished the effect of VEGF in the fetus and reversed 
the effect of VEGF in the adult. Error bars indicate SEM for arteries from a total of 31 
animals: 7 Normoxic Fetal, 5 Hypoxic Fetal, 11 Normoxic Adult, and 8 Hypoxic Adult. 
All differences denoated * are at P < 0.05.  
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Figure 6. Hypoxia Alters the Receptor that VEGF Alters Stretch-Induced Stress. 
Endothelium-denuded common carotid arteries from fetal and adult sheep maintained at 
normoxic settings (N, sea level) or hypoxic settings (H, 3280 m for 110days) were placed 
in 48hrs Organ Culture (OC) with 0ng/mL VEGF (Control), 3ng/mL VEGF (VEGF), or 
3ng/mL VEGF + 240nM Vatalanib (VEGF+Vatalanib) then underwent contractility assay. 
Stretch induced (myogenic) contraction was determined at increasing multiples of the 
unstressed diameter (D0). Error bars indicate SEM for arteries from a total of 31 animals: 
7 Normoxic Fetal, 5 Hypoxic Fetal, 11 Normoxic Adult, and 8 Hypoxic Adult. All 
differences denoated * are at P < 0.05. 
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Discussion 
The present study offers five original observations in endothelium-denuded 
carotid arteries. First, Hypoxic acclimatization ablated the age-dependent contractile 
response to VEGF in fetal and while reversing the effect in adult arteries shown 
previously (22). Second, hypoxic acclimatization alters the response to a second exposure 
to VEGF in organ culture with increased abundance of both NM-MC and SM-MHC 
throughout the medial wall in the fetus while VEGF decreases NM-MHC and increases 
SM-MHC abundance through the medial wall in the adult. Third, hypoxic acclimatization 
alters re-organization of myosin heavy chains and actin by VEGF, decreasing total MHC 
and SM-MHC coloclization with SM-AA in fetal and adult arteries. Fourth, selective 
inhibition of both VEGF receptor 1 (Flt-1) and VEGF receptor 2 (KDR) with Vatalanib 
ablated the contractile effect of VEGF in organ culture in adult but not fetal arteries. 
Fifth, both VEGF receptors were significantly more abundant in adult arteries relative to 
protein standard, with similar levels of VEGFR1 in both age groups and nearly 3 fold 
greater for VEGFR2 in the adult compared with fetus. Together, these observations 
support the hypothesis that hypoxic acclimatization alters the vascular response to VEGF 
and downstream changes in artery structure and function through changes in contractile 
protein abundance and organization secondary to changes in smooth muscle phenotype. 
 
Hypoxic Acclimatization Altered Artery Structure and Function 
Hypoxic acclimatization alters artery wall thicknesses in different ways 
depending on artery type, size, and age (27, 41, 48) and can act differently on any or all 
layers of the artery wall including the endothelial, medial and adventitial layers (40, 47). 
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To more fully understand hypoxic changes to artery structure and the functional 
implications, the present study focused on the medial layer that contains the smooth 
muscle cells responsible for contractile force. Although hypoxic acclimatization did not 
alter baseline medial thickness in either adult or fetal ovine carotid arteries, organ culture 
with VEGF increased medial thickness in hypoxic fetal arteries while decreasing medial 
thickness in hypoxic adult arteries. Coupled with the increased contractile force seen in 
the adult, this suggests a possible shift toward a more contractile SMC associated with 
either an increase in contractile protein abundance or organization within the vascular 
smooth muscle. 
As described previously (22), most vascular studies measure the contractile 
response as a percentage response to a standardized contractant such as high potassium or 
in units of gram for a single segment length. This method is internaly normalized but 
does not consider changes in wall thickness, stiffness, content of contractile protein, or 
optimum stretch length, all of which can significantly affect comparisons across various 
chronic treatment groups. Therefore the experimental approach applied in this study 
applied a complete stress-strain length-tension protocol where the contractile response 
was quantified as changes in active stresses in units of force per medial cross-sectional 
area for multiple degrees of arterial strain, as described previously (6). As seen in earlier 
studies, these measurements revealed (Figure 1) that K+-induced contractions were 
greater in adult than fetal arteries (6), were not altered much by hypoxia but were 
inversely responsive to VEGF in adult and lost response to VEGF in fetal arteries (27). 
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Hypoxic Acclimatization Altered VEGF-Induced Change in MHC Abundance 
and Organization 
We explored the hypothesis that hypoxic acclimatization that changes artery 
structure and contractility may be due to changes in smooth muscle phenotype, and that 
hypoxia may alter regulation of these changes when exposed to a second insult. To 
quantify this change in response, experiments were done to assess changes in MHC 
isoform abundance that is considered to be synonymous with contractile capacity and 
smooth muscle phenotype (16, 17, 36). The artery wall contains a heterogenous 
distribution of SMC phenotype and morphology (12, 41) which led us to incorporate the 
relative abundance determined via immunoblots across the artery wall using radial line 
scans of fluorescent intensity in coronal section that had been immunostained for the 
desired protein, as described previously (6).  
This method revealed that embryonic isoforms of MHC (NM-MHC) that are 
generally prevalent in functionally immature and proliferative smooth muscle cells (11, 
31, 36) were indeed more abundant in fetal than adult arteries and increased with hypoxia 
for both age groups (data not shown).  VEGF following hypoxic acclimatization 
significantly changes in all 3 layers in a gradient like fashion with the greatest change in 
the lumen greater than the medial greater than the adventitial portion of the media. While 
hypoxia did not alter this distribution pattern, it did heighten the response to VEGF in the 
fetal artery with increased abundance of both the immature NM-MHC and the mature 
contractile SM-MHC. In adult arteries, Vegf increased NM-MHC while decreasing SM-
MHC, with both of these effects amplified by hypoxic acclimatization (Figure 2). 
Together, these results suggest that hypoxic acclimatization alters the receptor or 
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intracellular coupling of VEGF with MHC isoforms expression and the gradient effect 
suggests that the point of vasotrophic stimulus may be laminar in location. The lamellar 
heterogeneity may simply be a non-functional consequence but it may also be suggestive 
of the importance of organized heterogeneity of SMC phenotypes within the arterial wall 
to maintain vascular homeostasis with dynamic interaction between contractile and 
secretory functions. 
 
Hypoxic Acclimatization Altered VEGF Receptor Mediating the Contractile 
Response 
In the adult, the selective VEGF receptor inhibitor Vatalanib did successfully 
inhibit the contractile effects of organ culture with VEGF for both K+-induced and 
stretch-induced stress. This was not altered by hypoxia. In fetal arteries, normalized 
stretch-induced stress diminished with VEGF and hypoxia ablated both the effect of 
VEGF and therefore the effect of VEGF inhibition. This disconnect between the effects 
of hypoxia on K+-induced and stretch-dependent (myogenic) contractions suggests that 
hypoxic acclimatization can affect certain components of the contractile apparatus 
differentially and may preferentially affect mechanisms that couple stretch to contraction. 
Possible mechanisms involved in this selective effect of hypoxia include calcium 
channels involved in mechanotransduction (19) and contractile proteins involved in 
myogenic determination of myofilament calcium sensitivity (8, 38). Interestingly, many 
of these mechanisms are strongly influenced by phenotypic transformation of smooth 
muscle (8, 21, 45). As recently shown by our lab, VEGF receptor prevalence of type and 
 141 
abundance differs throughout development with greater expression in the adult (1) and 
upregulated with chronic hypoxia. 
 
Overview 
Together, the results of the present study demonstrate that hypoxic 
acclimatization alters the response to VEGF and downstream changes in contractility, 
MHC isoform abundance and MHC-SM-AA organization that all implicate a change in 
SMC phenotype. 
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CHAPTER FIVE 
SUMMARY AND FUTURE DIRECTIONS 
 
Summary 
The purpose of this dissertation was to define how hypoxic vascular remodeling 
alters artery structure and function, and how changes in smooth muscle phenotype 
contribute to these changes. In chapter 2, we determined that hypoxic vascular 
remodeling does alter vascular contractility, that it is associated with a re-organization of 
contractile proteins that may represent a change in SMC phenotype, and that VEGF is 
likely to contribute to this process. Transmural quantification of contractile proteins was 
also able to distinguish a gradient pattern of distribution suggesting possible sources of 
vasotrophic factors that may have contributed to the hypoxic vascular remodeling. 
Similarly, the organization of the contractile proteins was found to correlate much more 
strongly with contractile behavior in contrast to the previously used protein abundance 
suggesting that SMC phenotype may be better identified with colocalization of 
established proteins. 
In chapter 3, our goal was to identify the endothelial component of hypoxia and 
VEGF on transitions between SMC phenotype populations in the artery wall and 
determine if NO mediated this process at all. To this end, we assessed the effect of VEGF 
in organ culture of normoxia and hypoxia acclimatized arteries, with and without the 
endothelium, for changes in contractile function and SMC phenotype. We applied a novel 
characterization method to help identify where on the spectrum of mature contractile to 
immature synthetic phenotypes the SMC were present and how this changed with 
hypoxia and VEGF. We inhibited eNOS with LNAME to determine if VEGF might be 
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acting through NO and found that both an NO-dependent and NO-independent 
contribution from the endothelium. 
Chapter 4 hoped to expand upon chapter 2 and 3 with consideration to how 
hypoxic acclimatization may program the tissue to respond differently to additional 
hypoxic insults. Similar methods as chapter 2 were utilized with endothelium-denuded 
carotid arteries from normoxic and hypoxic sheep cultured with and without VEGF to 
assess possible structural, contractile and phenotypic responses. As described, the 
response was age dependent, dramatically changed in the adult but with minimal to no 
response in the fetus. This contributes possible mechanism to the current thought that 
chronic hypoxia in utero has significant pathophysiological effects that the fetus carries 
on after birth. 
In this chapter, we briefly describe other contributing factors to this interplay of 
the smooth muscle, endothelium, and vasotrophic factors during hypoxic vascular 
remodeling. Endothelin is a prominent vasoconstrictor with acute exposure but has also 
been shown to induce a significant phenotypic shift toward the synthetic SMC. Below we 
stimulated endothelin with VEGF in the presence and absence of the endothelium as well 
as selectively inhibited receptors to identify which intracellular pathway led to the 
described phenotypic shifts. We also display colocalization findings using additional 
established and novel methods (Fluoview, Upper Right %, Colocalization index #2). We 
also report the negative finding of PKG activation that was investigated using denuded 
middle cerebral arteries, suggesting that downstream of endothelial NO activity, other 
kinases may also be at work. 
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Future Directions 
At the conclusion of this work, we are left with several important questions that 
may act as a spring board for future studies. We have now established that hypoxia alters 
SMC phenotype within the artery wall and that this is associated with functional changes 
in contractility and structured. We’ve also noted that this new phenotype appears to 
predispose the vessel to a different response to normal physiological stimulus. This 
would easily lend itself to testing with the several known factors in vascular remodeling 
and angiogenesis, including PDGF, FGF, TGF-b and some of the inflammatory factors 
active in atherosclerosis. An additional step forward would be an organ culture model 
that would allow control in vitro treatment with hydrostatic intra-luminal pressure and 
sheer force to more fully model the physiologic environment. An additional next step is 
in progress to partner these phenotypic changes with miRNA and transcription factor 
assays to identify additional regulators. This could also be assessed in the setting of a 
whole tissue environment following a controlled wound, with perturbation of various 
angiogenic factors including VEGF. With regard to vascular remodeling secondary to 
hypoxia and maturity, there are many areas of future research. This dissertation added 
several tools to quantify, describe, and categorize smooth muscle phenotype, as well as a 
greater understanding of its role in hypoxic vascular remodeling. 
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Figure 1.  Hypoxia Increases Role of PKG Driven SMC Phenotype Shift in 48hr 
Organ Culture.   
In Figure 1, hypoxia does not alter PKG mediation of MHC colocalization with AA. In 
Figure 5.1a, SM-MHC and AA colocalization: Please see discussion of Figure 3.5 (chapter 
3 above) for comparison among baseline controls for Normoxic (intact and denuded) and 
Hypoxic (intact and denuded) treatment groups.  Acute 24hr exposure to PKG activator 8-
pCPT increases Q1 quadrant in normoxic (more in denuded than intact arteries), and 
increases Q3 in hypoxic arteries. Figure 1, middle panels: 8-pCPT treatment of 
endothelium-intact normoxic arteries did not alter colocalization pattern at all. Hypoxia did 
not alter the influence 8-pCPT treatment in endothelium-intact arteries, but it did show a 
similar effect as VEGF but more modest. Hypoxia inverts the influence of VEGF treatment 
on Q1, Q2, and Q3 compared with normoxic. Hypoxia changes endothelial contribution to 
VEGF influence on SM-MHC and Actin colocalization (See Figure 5A, right panels). 8-
pCPT action through the endothelium differed significantly between normoxic and hypoxic 
arteries for all 3 quadrants and demonstrated a similar shift in SM-MHC and Actin 
colocalization as seen with VEGF but at a decreased magnitude. 
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Figure 2.  Hypoxia Increases Role of PKG Driven SMC Phenotype Shift in 48hr 
Organ Culture as Measured Using NM-MHC and AA Colocalization.   
For Figure 2 with NM-MHC and AA colocalization, see discussion of Figure 1 above for 
comparison among baseline controls for Normoxic (intact and denuded) and Hypoxic 
(intact and denuded) treatment groups. Acute 24hr exposure to 8-pCPT did not 
significantly alter any of the 3 quadrants when compared with control but did respond 
inversely to treatment for endothelium-intact vs endothelium-denuded arteries in both 
normoxic and hypoxic arteries.  Figure 2, middle panels: 8-pCPT treatment of 
endothelium-intact normoxic arteries did not significantly differ from control.  As with 
SM-MHC, hypoxia did not affect influence of 8-pCPT treatment in endothelium-intact 
arteries but did follow the pattern shift seen with VEGF on hypoxic endothelium-denuded 
arteries at a lesser magnitude. Hypoxia accents the influence of 8-pCPT treatment on 
endothelium-denuded arteries in all 3 quadrants, inverting the effect of the endothelium. 
Hypoxia changes endothelial contribution to 8-pCPT influence on NM-MHC and Actin 
colocalization (Figure 5.1b, right panels) for 8-pCPT action through the endothelium was 
inverted by hypoxia in all 3 quadrants. 
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Figure 3.  A separate quadrant analysis using Olympus confocal software for 
just UR% and threshold other than 50%.  (SM-MHC also labeled as SM2). 
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Figure 4.  A separate quadrant analysis using Olympus confocal software for 
just UR% and threshold other than 50%.  (NM-MHC also labeled as SMemb). 
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Figure 5.  Fluoview Colocalization- Endothelin Pathway. 
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Table 2.  Statistical Analysis of Fluoview Colocalization Data by Behrens–
Fisher for SM-MHC, Fetal Normoxic. 
SM-MHC 
Normoxic: 
 
 
  
By Behren Fischer Mass
Co-I #2Sig Difference UR/UR+UL Sig Difference
FN-SM2 Co-1 #2 UR/UR+LR UR% Thickness N vs H +E vs -E Tx vs StarvedN vs H +E vs -E Tx vs Starved
Tx Avg SE Avg SE Avg SE Avg SE Count (within tx) (within tx) (within Endo) (within tx) (within tx) (within Endo)
######### 0.1279634 0.007 43.199705 2.376 24.403 1.655 48.865452 0.932 154 155 155 155 155 155 155
-1 Fresh- Intact 0.086 0.029 5.983 4.669 5.983 4.669 54.232 1.208 4 - - - - X -
0Starved-Intact 0.169 0.024 55.774 8.540 20.550 2.330 45.848 1.878 12 - - - X - -
3 Vegf3-Intact 0.105 0.042 16.789 5.562 19.080 5.853 47.573 4.835 5 - - X X - X
10 Vegf10-Intact 0.103 0.026 18.717 6.794 18.717 6.794 46.463 3.438 10 - - X - X X
30 Vegf30-Intact 0.087 0.042 40.405 21.479 40.405 21.479 41.081 4.729 2 - - X - - -
0.128 0.007 43.200 2.376 24.403 1.655 48.865 0.932 154 - - -
-1Fresh-Denuded 0.114 0.033 16.796 3.898 20.093 2.401 41.948 5.445 5 - - - - X -
0Starved-Denuded 0.140 0.017 50.162 7.446 29.492 5.762 46.911 1.687 18 - - - * - -
3Vegf3-Denuded 0.053 0.012 20.228 9.163 20.228 9.163 44.300 2.191 4 X - X - - X
10Vegf10-Denuded 0.096 0.026 33.370 7.394 33.370 7.394 45.220 3.397 10 X - X - X X
30Vegf30-Denuded 0.071 0.029 17.003 3.600 17.003 3.600 44.788 1.867 3 X - X X - X
0.128 0.007 43.200 2.376 24.403 1.655 48.865 0.932 154 - - -
-E Denuded Ctrl -EStarved-Denuded 0.140 0.017 50.162 7.446 29.492 5.762 46.911 1.687 18 - - - X - -
Vegf -E Vegf10-Denuded 0.096 0.026 33.370 7.394 33.370 7.394 45.220 3.397 10 X - X - X X
8 pCPT -E8-pCPT-Denuded 0.119 0.022 57.855 6.831 38.735 3.253 47.787 4.249 14 X - - X - -
LNAME -EL-NAME-Denuded 0.166 0.022 65.786 6.004 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 8 - - - X - X
Vegf 10 + LNAME -EVegf10+L-NAME-Denuded 0.140 0.027 68.278 5.799 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 10 X - - X X X
+E Intact Ctrl+E Starved-Intact 0.169 0.024 55.774 8.540 20.550 2.330 45.848 1.878 12 - - - X - -
Vegf+E Vegf10-Intact 0.103 0.026 18.717 6.794 18.717 6.794 46.463 3.438 10 - - X - X X
8 pCPT+E 8-pCPT-Intact 0.125 0.026 64.744 8.151 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 8 - - - X - -
LNAME+E L-NAME-Intact 0.160 0.028 66.503 5.980 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 10 - - - X - -
Vegf 10 + LNAME+EVegf10+L-NAME-Intact 0.153 0.028 37.523 7.513 16.389 6.406 58.243 4.327 14 - - - - X X
0.128 0.007 43.200 2.376 24.403 1.655 48.865 0.932 154 - - -
Ctrl -E Starved-Denuded 0.140 0.017 50.162 7.446 29.492 5.762 46.911 1.687 18 - - X -
Vegf -E Vegf10-Denuded 0.096 0.026 33.370 7.394 33.370 7.394 45.220 3.397 10 X X - X
Vegf +E Vegf10-Intact 0.103 0.026 18.717 6.794 18.717 6.794 46.463 3.438 10 - X - X
Endothelin -E ET-100 0.177 0.065 36.554 11.269 36.554 11.269 53.500 7.521 5 - - - -
Vegf +BQ123 +EVegf10+BQ123 0.118 0.042 18.778 8.502 18.778 8.502 53.860 4.324 6 - - - X
Vegf +BQ788 +EVegf10+BQ788 0.070 0.027 22.054 9.778 22.054 9.778 57.999 5.859 6 X X - X
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Table 3.  Statistical Analysis of Fluoview Colocalization Data by Behrens–
Fisher for SM-MHC, Fetal Hypoxic. 
 
Hypoxic: 
 
 
 
  
Co-I #2Sig Difference UR/UR+UL Sig Difference
FH-SM2 Co-1 #2 UR/UR+LR UR% Thickness N vs H +E vs -E Tx vs StarvedN vs H +E vs -E Tx vs Starved
Tx Avg SE Avg SE Avg SE Avg SE Count (within tx) (within tx) (within Endo) (within tx) (within tx) (within Endo)
########## 0.1714644 0.008 34.799883 1.681 28.850 1.510 48.44071 0.996 157 155 155 155 155 155 155
-1 Fresh- Intact 0.151 0.077 27.152 18.079 27.152 18.079 47.452 2.894 2 - - - - - -
0 Starved-Intact 0.179 0.026 37.128 5.707 43.937 8.141 40.506 2.054 14 - - - X - -
3 Vegf3-Intact 0.146 0.055 38.229 3.472 38.229 3.472 50.528 9.211 4 - - - X - -
10 Vegf10-Intact 0.144 0.028 27.514 6.487 29.968 6.331 47.517 3.571 11 - - - - - -
30 Vegf30-Intact 0.108 0.055 35.435 12.037 35.435 12.037 44.224 12.416 4 - X X - - -
0.171 0.008 34.800 1.681 28.850 1.510 48.441 0.996 157 - - -
-1 Fresh-Denuded 0.266 #DIV/0! 51.535 #DIV/0! 51.535 #DIV/0! 42.132 #DIV/0! 1 - - - - - -
0Starved-Denuded 0.159 0.018 34.361 4.105 26.531 3.677 49.416 3.131 22 - - - X - -
3 Vegf3-Denuded 0.123 0.023 37.854 11.958 37.854 11.958 47.430 9.611 4 X - - - - -
10Vegf10-Denuded 0.158 0.029 31.539 6.234 31.539 6.234 45.313 2.870 9 X - - - - -
30Vegf30-Denuded 0.217 0.035 39.492 2.880 39.492 2.880 44.899 4.320 4 X X X X - -
0.171 0.008 34.800 1.681 28.850 1.510 48.441 0.996 157 - - -
-E Denuded Ctrl -EStarved-Denuded 0.159 0.018 34.361 4.105 26.531 3.677 49.416 3.131 22 - - - X - -
Vegf -EVegf10-Denuded 0.158 0.029 31.539 6.234 31.539 6.234 45.313 2.870 9 X - - - - -
8 pCPT -E8-pCPT-Denuded 0.162 0.019 40.727 7.707 12.220 3.525 46.125 0.982 14 X - - X - -
LNAME -EL-NAME-Denuded 0.215 0.042 42.331 6.880 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 10 - - X X - -
Vegf 10 + LNAME -EVegf10+L-NAME-Denuded 0.244 0.040 48.875 7.017 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 10 X X X X X X
+E Intact Ctrl+E Starved-Intact 0.179 0.026 37.128 5.707 43.937 8.141 40.506 2.054 14 - - - X - -
Vegf+E Vegf10-Intact 0.144 0.028 27.514 6.487 29.968 6.331 47.517 3.571 11 - - - - - -
8 pCPT+E 8-pCPT-Intact 0.162 0.030 31.113 6.576 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 10 - - - X - -
LNAME+E L-NAME-Intact 0.164 0.032 38.320 6.130 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 9 - - - X - -
Vegf 10 + LNAME+EVegf10+L-NAME-Intact 0.173 0.024 31.790 5.597 17.633 1.960 53.624 2.287 15 - X - - X -
0.171 0.008 34.800 1.681 28.850 1.510 48.441 0.996 157 - - -
Ctrl -EStarved-Denuded 0.159 0.018 34.361 4.105 26.531 3.677 49.416 3.131 22 - - X -
Vegf -EVegf10-Denuded 0.158 0.029 31.539 6.234 31.539 6.234 45.313 2.870 9 X - - -
Vegf +E Vegf10-Intact 0.144 0.028 27.514 6.487 29.968 6.331 47.517 3.571 11 - - - -
Endothelin -E ET-100 0.255 0.041 36.022 8.532 36.022 8.532 72.230 2.649 4 - X - -
Vegf +BQ123 +EVegf10+BQ123 0.116 0.033 13.738 4.177 13.738 4.177 47.288 1.608 5 - X - *
Vegf +BQ788 +EVegf10+BQ788 0.162 0.040 12.715 4.394 12.715 4.394 50.660 3.062 5 X - - X
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Table 4. Statistical Analysis of Fluoview Colocalization Data by Behrens-Fisher for 
NM-MHC, Fetal Normoxic 
 
NM-MHC 
Normoxic: 
 
  
By Behren Fischer Mass
Co-I #2Sig Difference UR/UR+UL Sig Difference
FN-Smemb Co-1 #2 UR/UR+LR UR% Thickness N vs H +E vs -E Tx vs StarvedN vs H +E vs -E Tx vs Starved
Tx Avg SE Avg SE Avg SE Avg SE Count (within tx) (within tx) (within Endo) (within tx) (within tx) (within Endo)
######### 0.1013115 0.005 18.503985 0.924 17.861 1.147 49.304644 0.919 152
-1 Fresh- Intact 0.113 0.039 16.314 4.173 14.386 4.274 54.879 1.137 5 - - - X - -
0Starved-Intact 0.126 0.015 20.043 3.086 17.113 5.651 45.848 1.804 13 - - - X - -
3 Vegf3-Intact 0.131 0.016 15.120 1.653 15.120 1.653 44.811 5.123 4 - X - - - -
10 Vegf10-Intact 0.060 0.010 18.150 4.823 18.150 4.823 49.191 3.558 10 X - X X - -
30 Vegf30-Intact 0.081 0.000 7.330 0.138 7.330 0.138 41.081 4.729 2 X - X X - X
0.101 0.005 18.504 0.924 17.861 1.147 49.305 0.919 152 -
-1Fresh-Denuded 0.097 0.043 20.961 8.922 20.961 8.922 44.858 5.942 4 - - - - - -
0Starved-Denuded 0.118 0.014 18.701 2.808 17.927 3.276 46.911 1.687 18 - - - - - -
3Vegf3-Denuded 0.069 0.016 9.288 4.176 9.288 4.176 44.300 2.191 4 - X X X - X
10Vegf10-Denuded 0.055 0.016 18.320 3.930 18.320 3.930 45.220 3.397 10 - - X X - -
30Vegf30-Denuded 0.109 0.021 12.679 5.919 12.679 5.919 46.225 1.951 4 - - - X - -
0.101 0.005 18.504 0.924 17.861 1.147 49.305 0.919 152
-E Denuded CtrlStarved-Denuded 0.118 0.014 18.701 2.808 17.927 3.276 46.911 1.687 18 - - - - - -
Vegf Vegf10-Denuded 0.055 0.016 18.320 3.930 18.320 3.930 45.220 3.397 10 - - X X - -
8 pCPT8-pCPT-Denuded 0.098 0.014 21.772 4.098 26.985 6.089 48.909 4.855 13 - - - - - -
LNAMEL-NAME-Denuded 0.143 0.005 18.645 2.355 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 9 - - X - - -
Vegf 10 + LNAMEVegf10+L-NAME-Denuded 0.145 0.018 18.470 2.530 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 8 - X - X - -
+E Intact Ctrl+EStarved-Intact 0.126 0.015 20.043 3.086 17.113 5.651 45.848 1.804 13 - - - X - -
Vegf+E Vegf10-Intact 0.060 0.010 18.150 4.823 18.150 4.823 49.191 3.558 10 X - X X - -
8 pCPT+E 8-pCPT-Intact 0.122 0.019 20.238 2.171 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 9 X - - X - -
LNAME+EL-NAME-Intact 0.159 0.016 18.065 1.814 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 8 - - X - - -
Vegf 10 + LNAME+EVegf10+L-NAME-Intact 0.102 0.016 17.847 2.020 16.892 2.687 58.243 4.327 14 - X - - - -
0.101 0.005 18.504 0.924 17.861 1.147 49.305 0.919 152
Ctrl -EStarved-Denuded 0.118 0.014 18.701 2.808 17.927 3.276 46.911 1.687 18 - - - -
Vegf -EVegf10-Denuded 0.055 0.016 18.320 3.930 18.320 3.930 45.220 3.397 10 - X X -
Vegf +E Vegf10-Intact 0.060 0.010 18.150 4.823 18.150 4.823 49.191 3.558 10 X X X -
Endothelin -E ET-100 0.047 0.013 25.104 9.942 25.104 9.942 50.358 7.293 5 X X - -
Vegf +BQ123 +EVegf10+BQ123 0.035 0.009 22.625 7.044 22.625 7.044 53.860 4.324 6 - X X -
Vegf +BQ788 +EVegf10+BQ788 0.029 0.008 14.320 4.838 14.320 4.838 57.999 5.859 6 X X - -
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Table 5. Statistical Analysis of Fluoview Colocalization Data by Behrens-Fisher for 
NM-MHC, Fetal Hypoxic 
 
 
Hypoxic: 
 
 
Co-I #2Sig Difference UR/UR+UL Sig Difference
FH-Smemb Co-1 #2 UR/UR+LR UR% Thickness N vs H +E vs -E Tx vs StarvedN vs H +E vs -E Tx vs Starved
Tx Avg SE Avg SE Avg SE Avg SE Count (within tx) (within tx) (within Endo) (within tx) (within tx) (within Endo)
########## 0.1103068 0.006 25.85056 1.801 30.016 2.261 47.716341 1.054 155 155 155 155 155 155 155
-1 Fresh- Intact 0.215 0.038 84.893 1.007 84.893 1.007 47.452 2.894 2 - - - X - -
0 Starved-Intact 0.120 0.018 28.177 5.752 39.918 7.935 40.506 1.984 15 - - - X - -
3 Vegf3-Intact 0.104 0.029 21.344 5.935 21.344 5.935 50.528 9.211 4 - - - - X -
10 Vegf10-Intact 0.095 0.018 31.499 9.021 31.499 9.021 47.116 4.389 9 X - - X - -
30 Vegf30-Intact 0.040 0.014 30.062 13.892 30.062 13.892 44.324 9.618 5 X X X X - -
0.110 0.006 25.851 1.801 30.016 2.261 47.716 1.054 155 155 155 155 155 155 155
-1 Fresh-Denuded 0.033 #DIV/0! 71.490 #DIV/0! 71.490 #DIV/0! 42.132 #DIV/0! 1 - - - - - -
0Starved-Denuded 0.099 0.015 21.168 4.367 21.637 5.796 48.205 3.377 21 - - - - - -
3 Vegf3-Denuded 0.090 0.019 43.176 12.613 43.176 12.613 47.430 9.611 4 - - - X X X
10Vegf10-Denuded 0.085 0.032 35.876 13.715 43.494 14.902 44.108 2.955 8 - - - X - X
30Vegf30-Denuded 0.134 0.056 43.858 11.164 43.858 11.164 40.805 3.794 6 - X - X - X
0.110 0.006 25.851 1.801 30.016 2.261 47.716 1.054 155 155 155 155 155 155 155
-E Denuded Ctrl -EStarved-Denuded 0.099 0.015 21.168 4.367 21.637 5.796 48.205 3.377 21 - - - - - -
Vegf -EVegf10-Denuded 0.085 0.032 35.876 13.715 43.494 14.902 44.108 2.955 8 - - - X - X
8 pCPT -E8-pCPT-Denuded 0.118 0.028 18.445 3.445 6.284 0.415 44.395 0.422 13 - - - - X -
LNAME -EL-NAME-Denuded 0.146 0.024 22.198 4.684 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 10 - - X - - -
Vegf 10 + LNAME -EVegf10+L-NAME-Denuded 0.167 0.031 27.156 5.384 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 10 - X X X - -
+E Intact Ctrl+E Starved-Intact 0.120 0.018 28.177 5.752 39.918 7.935 40.506 1.984 15 - - - X - -
Vegf+E Vegf10-Intact 0.095 0.018 31.499 9.021 31.499 9.021 47.116 4.389 9 X - - X - -
8 pCPT+E 8-pCPT-Intact 0.080 0.014 29.612 6.467 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 10 X - X X X -
LNAME+E L-NAME-Intact 0.168 0.031 19.695 3.555 #DIV/0! #DIV/0! #DIV/0! #DIV/0! 10 - - X - - -
Vegf 10 + LNAME+EVegf10+L-NAME-Intact 0.100 0.014 18.585 4.930 8.067 1.482 55.118 2.446 15 - X - - - X
0.110 0.006 25.851 1.801 30.016 2.261 47.716 1.054 155 155 155 155 155 155 155
Ctrl -E Starved-Denuded 0.099 0.015 21.168 4.367 21.637 5.796 48.205 3.377 21 - - - -
Vegf -E Vegf10-Denuded 0.085 0.032 35.876 13.715 43.494 14.902 44.108 2.955 8 - - X X
Vegf +E Vegf10-Intact 0.095 0.018 31.499 9.021 31.499 9.021 47.116 4.389 9 X - X -
Endothelin -E ET-100 0.118 0.011 16.545 9.232 31.654 5.225 72.230 2.649 4 X - - -
Vegf +BQ123 +EVegf10+BQ123 0.033 0.018 10.157 2.796 10.157 2.796 47.759 1.669 5 - X X X
Vegf +BQ788 +EVegf10+BQ788 0.050 0.010 11.402 4.515 11.402 4.515 53.981 3.097 3 X X - X
